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ABSTRACT
Cytotoxic Effects of Electron Carriers Are Inhibited by HSP27 in Breast Cancer
Cell Lines
by
Yvonne C Giraud
Dr. Stephen W. Carper, Examination Committee Chair 
Associate Professor of Chemistry 
University of Nevada, Las Vegas
Human breast cancer cell lines DC4, DB46, MCF-7, MDA-MB-435 were incubated 
with cytochrome c at 5x10"’ M, 5x10^ M and 5x10'^ M Human colon cancer cell line, 
RKO, and normal human lung fibroblast cell line, HFLl, were incubated with 
cytochrome c at 5.6x10'^M, 5.6x10'’ M and 5.6x10"^M. Cytochrome c exposure showed 
a dose response including cell death in breast cancer cell lines. RKO showed no 
sensitivity to cytochrome c exposure at any of the concentrations and HFLl showed 
sensitivity only at the highest concentration. FAD, NADH, Qio and ATP were incubated 
with cells at 1x10'  ^M, IxlO'^M and 1x10'^ M. Incubation of FAD with DC4 and DB46 
was also done at SxlO'^M, 5x10"  ^M and 5x10'^ M. FAD, ATP and NADH were more 
effective in cell death induction at much lower concentrations than cytochrome c. Qio 
was least effective in cell death induction.
Ill
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CHAPTER 1 
INTRODUCTION
The following subchapters will discuss the concepts of heat shock proteins, heat shock 
protein 27, apoptosis, caspases, mitochondria, electron carriers and cancer. The 
subsequent hypotheses derived from these concepts are stated on page 22.
Heat Shock Proteins
The name heat shock proteins (HSPs) was coined in 1962 as Ritossa discovered that a 
certain group of proteins became expressed in Drosophila larvae following exposure to 
temperatures that were above those allowing optimal growth (1). Through fiirther 
research by Tissières it was soon realized that high temperatures were not the only 
method of induction (2,3). Tissières et al. showed that metals, amino acid analogs and 
anoxia were able to elicit similar responses; hence, HSPs are also referred to as stress 
proteins. HSPs are divided into five major families according to their molecular weight: 
HSPlOO, 90, 70, 60 and the small HSPs (sHSPs)/a-crystallins (3). sHSPs are 
evolutionary related to a-crystallin which is known to be a major structural protein of the 
vertebrate eye lens. A common characteristic of the a-crystallin/sHSP family is a 
conserved homologous sequence of 90-100 residues (4). sHSPs/a-crystallins form a 
diverse family of proteins, are between 15-30 kDa in size and can be induced by mild
1
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heat shock or other forms of stress. They have a tendency to aggregate and are involved 
in protein-protein interactions (4).
HSPs are found in all organisms from bacteria to humans and are among the most 
conserved proteins. The synthesis of HSPs allows an organism to gain tolerance to insult. 
An insult constitutes elevated temperature or stress. It was found that HSPs are 
synthesized in stressed cells as well as in unstressed cells, leading to the understanding 
that HSPs fiilfilled another function. The major role for large HSPs, which are HSPlOO, 
90, 70 and 60, appears to be molecular chaperones (3,4). Molecular chaperones have 
been defined as proteins that bind to and stabilize an otherwise unstable conformer of 
another protein. The controlled binding and release of the client protein determines its 
correct fate in vivo, which may be folding, oligomeric assembly, transport to a particular 
subcellular compartment or controlled switching between active versus inactive 
conformations (2). HSPlOO/Clp proteins protect cells under stress conditions. They 
function as chaperones, solubilize protein aggregates in an ATP-dependent manner and 
lead either to renaturation or proteolytic degradation of individual proteins (3). HSP90 
under normal conditions is an abundant, essential, cytosolic protein that in a complex 
with other proteins engages steroid receptors to possibly maintain them in an inert, folded 
state allowing for the binding with and reaction to the correct steroid signal (3). Stressed 
cells show a marked increase of HSP90 (3). HSP70 is a constitutive and stress-inducible 
protein. It binds to nascent polypeptide chains on ribosomes, maintains the membrane 
translocation-competent state of the precursor proteins, assists protein transport into 
mitochondria and the endoplasmic reticulum and also protects proteins under stress (3).
HSP60 belongs to the chaperonin family, which includes GroEL, from bacteria among
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
others, which is a group of proteins with a distinct ring-shaped, or toroid (double donut) 
quartenary structure. The chaperonins appear to mediate native folding of proteins in an 
ATP-dependent manner, which seems to proceed through cooperation of HSP70 (3). It is 
suggested that in this way large HSPs contribute to the maintenance and restoration of 
cellular homeostasis during and after stress (3). The focus of this discussion will now 
turn to the small heat shock protein 27, HSP27, and its role in programmed cell death 
(apoptosis).
Heat Shock Protein 27 
HSP27 belongs to the family of sHSP/a-crystallin. This small heat shock protein is 
constitutively expressed in many cell types and tissues at specific stages of development 
and differentiation (5). A variety of stimuli including elevated temperature, oxidative 
stress, staurosporine. Fas ligand and cytotoxic drugs induce HSP27 protection against 
apoptosis (5). Intracellular localization, level of oligomerization and phosphorylation 
status seem to determine the biological reactivity of HSP27 (2). Nonphosphorylated 
HSP27 exists in large complexes made up of about 24 subunits (6 tetramers) while 
phosphorylated HSP27 forms small rod-like oligomers, which may be tetrameric. 
Dissociation of large oligomers to tetramers as a result of phosphorylation or of mutation 
of all three serine residues to aspartate has been shown to lead to a significant decrease in 
chaperone activity (6). HSP27 forms large oligomers, which can act as molecular 
chaperones in vitro and protect cells from heat shock and oxidative stress when 
overexpressed (6). The function of a molecular chaperone is to prevent unfolded proteins 
from irreversible aggregation (6). In corporation with other factors, e.g. HSP70 and ATP,
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HSP27 helps to facilitate productive refolding of unfolded proteins (6). HSP27 shows 
stress-induced increase in expression as well as phosphorylation (11). The 
phosphorylation and stress-induced expression of HSP27 shows different kinetics leading 
to the assumption that the phosphorylation of the pre-existing constitutively expressed 
sHSPs is a first phase stress response and the elevated expression at a time when their 
phosphorylation is already down-regulated comprises the second phase (6).
A commonality found between a-crystallin and HSP27 is their phosphorylation at 
specific serine residues. The mammalian HSP27 has three major phosphorylation sites, 
which are at Ser-15, Ser-78 and Ser-82 (4,7). The monomeric, non-phosphorylated 
HSP27 has been shown to be the only form that inhibits actin polymerization in vitro (2). 
Elevated levels of HSP27, particularly phosphorylated isoforms, have been associated 
with increased resistance of human breast cancer cells to doxorubicin (4). Doxorubicin is 
an anticancer drug that inhibits both DNA and RNA synthesis and has preferential 
toxicity for cells in the S phase of the cell cycle (8).
It has been suggested that the phosphorylation of HSP27 is a possible signal for 
development of thermotolerance (4). A shift from the unphosphorylated to the 
phosphorylated isoforms of HSP27 within minutes after heat shock associated with the 
rapid translocation of the small HSPs from cytosol to nucleus has been observed in HeLa 
cells (4). Heat-induced phosphorylation of HSP27 is reduced in thermotolerant cells, as 
is the redistribution from cytoplasm to nucleus (4). Rapid stress-induced phosphorylation 
is induced by a p38 MAP (mitogen-activated protein) kinase cascade with subsequent 
activation of MAPKAP (mitogen-activated protein kinase-activated protein) kinases 2 
and 3, which directly phosphorylate mammalian sHSPs at several distinct sites (6).
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Increased phosphorylation of mammalian sHSPs occurs in response to a number of 
mitogenic stimuli including serum, growth factors and tumor promoters. Calcium 
ionophores and chelators, cadmium, arsenite, cycloheximide and phorbol esters are 
known to induce phosphorylation at normal growing temperature (4).
HSP27 is an estrogen responsive protein (4,9,10). The estrogen receptor, in absence 
of hormone, is not bound to its respective hormone response element (HRE). The 
hormone receptors are present within the nucleus bound to a complex consisting of two 
molecules of HSP90, one molecule of HSP70 and other proteins (11). Upon hormone 
binding, the receptors are released from the HSP complex (11). This homodimer has a 
greatly increased affinity for binding to HREs in DNA. The HREs are usually found 
several hundred base pairs upstream of target genes (11). The estrogen homodimer can 
bind to the HRE in the promoter region of the HSP27 gene and transcription of the 
HSP27 gene is initiated. Thus, when estrogen is present the HSP27 protein can become 
expressed in elevated levels (12).
Elevated levels of HSP27 may be in response to environmental stresses or exposure 
to estrogen (10). HSP27 is overexpressed in several human breast carcinomas and 
correlates well with their levels of estrogen receptors (9). It has been postulated that 
there is a link with hormone response (9). Treatment of human breast cancer cell lines 
withI7 P-estradiol was able to elicit HSP27 expression (10). Breast cancer cell lines 
overexpressing HSP27 showed an increase in cell survival when treated with doxorubicin 
or heat (10). HSP27 has been shown to correlate with the oncogenic status of cells and 
plays a role in their tumerogenicity (9). Well differentiated tumors have been shown to 
have the highest levels of HSP27 (9). It has been found that estrogen^ HSP27^ tumors
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recur more rapidly than estrogen  ^HSP27' tumors (9). High levels of HSP27 have been 
found to correlate with a shorter disease-free survival period in lymph node-negative 
patients but showed prolonged survival from first occurrence (9). Elevated levels of 
HSP27 in advanced cancers have been shown to be indicative of long survival. It is not 
understood why the overall survival of the patient is not affected with a high recurrence 
of the cancer (9).
HSP27 has been shown to block apoptosis induced by Fas (death cell surface receptor 
belonging to the tumor necrosis factor (TNF) superfamily of surface receptors) as it binds 
to Daxx (13). Daxx is an adapter protein that is normally associated with the nuclear 
substructures named ND-10 or PME oncogenic domain (POD) (13,14). This adapter 
protein can bind to the Fas receptor, mediate Fas-induced apoptosis and activate 
apoptosis signal-regulated kinase 1 (Ask 1) (13). Activation of this kinase can then 
activate the stress-activated protein kinase 1-Jun N-terminal kinase (SAPKl/JNK) (13). 
Thus, the binding of HSP27 to Daxx prevents the interaction of Daxx with Fas (13).
In neurodegenerative diseases such as Parkinson’s disease, Alzheimer’s disease, 
amyotropic lateral sclerosis and progressive supranuclear palsy the production of reactive 
oxygen species (ROS) has been implicated in the pathogensis. Unphosphorylated, large 
oligomers of HSP27 protect the cell against ROS and play a role in confluent-dependent 
resistance (15,16).
Cells in a tissue culture flask become confluent as a result of space limitation resulting 
in the cells making contact with neighboring cells via their cell walls. It is believed that 
confluent cultures are better models than actively growing cells for growth conditions in 
a solid tumor (16). It has been reported that cancer cell sensitivity to most anticancer
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drugs continuously decreased as cells reached confluence (16). Some of the mechanisms 
proposed to explain confluence-dependent resistance include decreased intracellular drug 
accumulation, modifications of the drug target in confluent cells and decreased ability of 
confluent tumor cells to undergo cell death in response to specific damage induced by the 
drug (16).
It is suggested that the protection that HSP27 confers against oxidative stress is 
independent of its ability to bind cytochrome c, which is an electron carrier in the 
mitochondrial electron transport chain (15). HSP27 has been shown to play a significant 
role in inhibiting apoptosis by binding to cytochrome c (5,17,18). It appears that both, in 
vitro chaperone properties and the ability to protect against oxidative stress depend on the 
existence of large oligomers of HSP27 meaning that in vivo chaperoning by HSP27 is the 
basis for its protective activity at the cellular level (6).
Apoptosis
Apoptosis plays a pivotal role in maintaining the balance between cell proliferation, 
regulation of healthy development, and protection against disease (14). It is involved in 
fundamental processes such as the regulation of immune cell maturation, target cell death 
induction by cytotoxic T lymphocytes and natural killer (NK) cells as well as the 
response of hormone-growth-factor-dependent tissues to the addition or withdrawal of 
ligands (14). Apoptosis is a morphologically distinct form of cell death characterized by 
rapid removal of unwanted and potentially dangerous cells. The inappropriate regulation 
of apoptosis is associated with a variety of diseases, including cancer, AIDS, 
neurodegenrative diseases and ischemic stroke (19).
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8Cells undergoing apoptosis are characterized by distinct morphological alterations 
including cell shrinkage, nuclear condensation, and the blebbing of apoptotic vesicles 
containing intracellular components. Those vesicles are specifically recognized and 
engulfed by phagocytic cells; hence, an inflammatory response is not elicited because 
intracellular contents are not released into the extracellular environment (14). Apoptosis 
is fiindamentally different from necrosis. Necrosis is the result of acute cellular 
disfunction due to extreme trauma or injury to the cell. This passive and disruptive 
process results in rapid loss of ion flux, leading to the uptake of water, which gives rise to 
cell and organelle swelling ending in cytolysis. The release of the cell contents into 
surrounding tissue solicits a local inflammatory response (2).
Characteristic biochemical alterations that occur during apoptosis include DNA 
cleavage between nucleosomes to form fragments that are multiples of approximately 
180 basepairs and/or into 50-to 300-kb fragments, the reorientation of phosphatidylserine 
from the cytoplasmic to the extracellular face of the plasma membrane and the loss of the 
mitochondrial membrane potential (14).
Cells are exceptionally sensitive to small changes in their environment and have to be 
able to adapt quickly to new conditions. Many times a rapid response is facilitated by the 
constitutive expression of key components of signal transduction or effector pathways 
(14). Many cells are able to undergo apoptosis in the presence of inhibitors of 
macromolecular synthesis, leading to the indication that the distal components of the 
apoptotic pathway are constitutively expressed. It has been shown that such inhibitors 
are capable of inducing apoptosis in some cell lines independent of additional stimulus. 
Thus, it appears that the constitutively expressed effectors of apoptosis are normally
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
inhibited by suppressive molecules (14). The apoptotic pathways were elucidated from 
studies performed in the nematode Caenorhabditis elegans (14,20-27). It was discovered 
that the gene ced-3 shares homology with a family of cysteine proteases known as 
caspases in higher animals (14). The term caspase refers to the enzymatic specificity:
Cys protease cleaving after residues (14,23,24,27). The human ced-A homologue is 
apaf-\ (apoptotic protease-activating factor-1).
Caspases
More than 14 caspases have been identified adding to the complexity of the pathways 
controlling apoptosis in higher animals (14,20,21). All caspases have similar amino acid 
sequences and substrate specificities, all cleave after an aspartic acid residue and all 
recognize a motif of at least four amino acids proximal to the cleavage site; yet, other 
structural elements must be required for substrate recognition since not all target proteins 
with a particular motif are cleaved (14).
Caspases are synthesized as proenzymes (zymogens), consisting of three domains (N- 
terminal prodomain together with large (~p20) and small (~plO) subunits), remain 
inactive in most healthy cells and require proteolytic cleavage to be active (16,14,18-24). 
Activation occurs as the single-chain procaspases are cleaved at specific aspartic acid 
residues to remove an inhibitory N-terminal pro-domain as well as cleavage at a specific 
recognition site between the large and small subunits to generate two distinct subunits. 
These differ from most non-caspase proteases, which are activated by removal of the 
inhibitory domain only (19,20). The resulting two subunits associate to form a
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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homodimer (14,19). Mature (activated) caspases form a tetramer, which consist of two 
homodimers bound together as two large and two small subunits (22).
Acitvated caspases exhibit considerable substrate specificity, particularly in relation 
to effector capases (20). Caspases that are involved in apoptosis are divided into two 
groups: group III, which is involved in the initiation of the apoptotic signal (initiator or 
apical caspases) and group II, which is involved in the disassembly of the cell (effector or 
down-stream executioner caspases) (17,14,20). Initiator caspases preferentially cleave at 
recognition sites that consist of the following four amino acid sequences YEXD (Y—>1, L, 
V and X ^any amino acid) whereas effector caspases prefer DEXD sequences (each 
capital letter represents an amino acid, listed in Table 1, p 23) (19). As mentioned earlier, 
all caspases exist in cells as inactive zymogens that have to be activated in order to be 
able to induce apoptosis. Effector caspases (e.g. caspase-3 or -7) are activated by 
initiator caspases (such as caspase-9) via cleavage at specific internal aspartate residues 
separating the large and small subunits (14,23,24,27).
There are two pathways that can induce the activation of initiator caspases. One 
pathway leading to caspase activation is initiated by engaging cell surface death receptors 
with their specific ligands and the other is known as mitochondrion-dependent apoptosis 
(14,27-29). An example of death receptor apoptosis will be briefly discussed and the 
focus will then be turned to mitochondrion-dependent apoptosis. In the apoptotic 
pathway of cell surface death receptors (Fig. 1, p. 26), a number of cytokines that belong 
to the tumor necrosis factor receptor (TNFR) superfamily (a family of transmembrane 
proteins) induce apoptosis (2,14,28,29). Mammalian death receptors include FAS/APO- 
1/CD95, TNFRl, DR-3/APO-3AVSL-1/TRAMP, and the TRAIL receptors
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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DR4/TRAIL-R1, DR5/TRAIL R2/TRICK2/ KILLER (14,28,29). These death receptors 
consist of characteristic cysteine-rich extracellular repeats but lack substantial homology 
in their cytoplasmic regions except in the death domain (14,28,29). The death domain 
spans approximately 80 amino acids and is required for the death signal transduction 
(13,14). Fas and TNFR share a region of homology at the death domain at the 
cytoplasmic face (68 amino acids), which is required for apoptotic signaling by both Fas 
and TNFR (14). The activation ligands for these death receptors are structurally related 
molecules that belong to the TNF gene superfamily; hence, Fas/CD95 ligand (FasL) 
binds to Fas, TNF and lymphotoxin a  bind to TNFRl, Apo 3 ligand (Apo3L) binds to 
DR3 and Apo2 ligand (Apo2L or TRAIL) binds to DR4 and DR5 (14,28,29). The Fas 
receptor is the only member that appears to act primarily in the apoptotic pathway. It is 
expressed in diverse tissues but is mainly involved in the modulation of the immune 
response (14). Binding of FasL to Fas receptor induces trimerization of Fas (19,28). A 
death domain-containing (DD- containing) adaptor molecule designated FADD/Moitl 
(Fas-associating protein with death domain/Mortl), which contains a DD at its C- 
terminus, is then recruited to the cytoplasmic region of Fas where it binds to the DD of 
Fas, which is then called the ligand bound-death receptor complex (death-inducing 
signaling complex or DISC) (14,19,28). The N-terminus of FADD, termed the death 
effector domain (DED) is essential for recruiting the upstream initiator procaspase-8 
and/or procaspase-10 (14,28,29). Procaspase-8 immediately undergoes autoactivation 
upon the recruitment to DISC and then activates procaspase-3. Procaspase-3 is the 
procaspase that mitochondrial-dependent apoptosis and death receptor apoptosis 
pathways converge on (14).
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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Another protein that normally localizes to sub-nuclear structures known as ND-10 or 
PODs (PML-oncogenic domains) can become associated with the Fas receptor (13,14). 
This protein is known as Daxx and its association with the Fas receptor activates the JNK 
(1-Jun N-terminal kinase) apoptotic pathway (14).
Death receptor induced apoptosis is regulated by three distinct mechanisms (28,29).
In the first mechanism the recruitment and/or activation of procaspase-8 at the DISC is 
prevented by a group of inhibitors belonging to a family of viral proteins, FADD-like 
ICE inhibitory proteins (vFLIPS) that contain two DEDs (28,29). The two DEDs 
compete with procaspases for binding to the DED of FADD; thus, preventing the 
recruitment of procaspases to the DISC (28,29). The mammalian homologue of vFLIP 
was identified and is known as Casper, I-FLICE, FLAME, CASHor MERIT (28). Two 
alternatively spliced forms of FLIP, FLIP-long and FLIP-short, exist (28). FLIP-long has 
a C-terminal that resembles caspase-8 but lacks protease activity because several 
conserved residues at the caspase active site are absent (28). Both isoforms of cellular 
FLIP bind to FADD, procaspase-8 and procaspase-10 by way of DED interactions (28).
A second mechanism is through the expression of decoy receptors for TRAIL (19,28). 
Decoy receptors are closely related to the TRAIL receptors DR4 and DR5. These 
receptors lack the cytoplasmic domain (DcRI) or contain a cytoplasmic region with a 
truncated death domain (DcR2), thereby specifically inhibiting TRAEL-induced apoptosis 
by sequestering the TRAIL ligand away fi"om the death receptors DR4 and DR5 (28).
The third mechanism involves viral protein crmA, a member of the serpin family that 
is a potent inhibitor or procaspase-8 (28). CrmA can inhibit the autoproteolytic activation 
of procaspase-8 as well as the ability of caspase-8 to cleave Bid, which leads to the
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release of cytochrome c from mitochondria resulting in the activation of downstream 
caspases (28).
Mitochondria
In mitochondrion-dependent apoptosis (Fig. 2, p. 27), mitochondria play a critical 
role in the induction of apoptosis by responding to a myriad of stimuli (30). In response 
to apoptotic stimuli these organelles release proteins into the cytosol that trigger caspase 
activation or other functions relevant to apoptosis, including cytochrome c, caspases, AIF 
(apoptosis-inducing factor), and SMAC/Diablo (second mitochondria-derived activator of 
caspases and murine homologue) (30,31).
A mitochondrion is a dynamic organelle comprised of an inner and outer membrane 
(32-34). Both membranes have differing levels of permeability and selectivity for 
cytoplasmic molecules and the organelle employs a diverse set of channels, pumps and 
transporters to move molecules across these membranes (32). Cytochrome c, whose gene 
resides in the nucleus as opposed to the mitochondria, is transported to the mitochondrial 
intermembrane space (IMS) upon synthesis (32). The addition of a heme group to 
cytochrome c serves to lock it in the IMS preventing its access to cytoplasmic apaf-\
(32). In the IMS, cytochrome c is a one-electron transfer %ent involved in the 
mitochondrial electron transport chain (30,33,34). Apo-cytochrome c (lacking the heme) 
does not activate apqf-\, thus protecting the cell from cytochrome c while it is being 
synthesized, transported and contained within the mitochondria (32). It is a possibility 
that a minimum level of cytochrome c is required to activate the apoptosome (32).
In healthy cells, mitochondria maintain an electrochemical gradient (A\\i) across their
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inner membranes that is created by pumping protons from the mitochondrial matrix 
to the mitochondrial IMS in conjunction with electron transport through the respiratory 
chain (30,33,34). The electrochemical gradient is made up of ApH (pH gradient) and AVm 
(electrical gradient) components and is essentially caused by protons that are driven out 
of the matrix to the outer surface of the inner membrane (30,33,34). This proton 
pumping therefore creates a pH gradient and an electrical gradient across the inner 
membrane (33,34). The influx of protons back into the matrix is believed to be mediated 
mainly by the FJFi-ATPase/lT pump (30,33).
Depolarization of mitochondria and loss of the electrochemical gradient (Av|i) is 
universally associated with apoptosis and cell death (30). A wide variety of apoptotic 
stimuli induce the release of cytochrome c from mitochondria prior to membrane 
depolarization (30,33,34). These stimuli include growth factor or neurotrophin 
withdrawal, DNA-damaging drugs, radiation, protein kinase inhibitors such as 
staurosporine, elevations of pro-apoptotic Bcl-2 family proteins, a variety of agonists or 
antagonists of the retinoid/steroid hormone family of nuclear receptors and cell surface 
death receptors (28,30). In response to these stimuli, mitochondrial depolarization 
typically occurs after caspase activation as a late event in the pathway (30).
There are four distinct protein complexes that make up the mitochondrial respiratory 
chain (Fig. 3, p. 28) (33,34). They are: (I) NADH-coenzyme Q reductase, (H) succinate- 
coenzyme Q reductase, (HI) coenzyme Q-cytochrome c reductase, and (IV) cytochrome c 
oxidase. Briefly, NADH donates electrons to Complex I, serving as a link between 
glycolysis, the TCA cycle, fatty acid oxidation and the electron transport chain (33,34). 
Complex I and II produce a common product, reduced coenzyme Q (UQH2), which
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becomes the substrate for Complex III (33,34). Complex III oxidizes UQH2 and reduces 
cytochrome c. Reduced cytochrome c then is the substrate for Complex IV and this is 
where molecular oxygen is reduced (33,34).
The release of cytochrome c prior to membrane depolarization and its role in the 
formation of the apoptosome has been of interest in cancer research. As already 
mentioned, cytochrome c is part of the electron transport chain. It also depends on other 
electron carriers of this chain for the transfer of electrons so that it can carry one electron 
at a time to Complex IV. These electron carriers will be discussed following this 
subchapter. What role these other electron carriers play in apoptosis regarding cancer 
treatment was investigated for this thesis.
The apoptotic induction of cytochrome c from mitochondria into the cytosol marks the 
beginning of caspase activation. Cytochrome c, which is present in the concentration of 
between 0.5 and 5 mM in the mitochondrial intermembrane space, is released from the 
mitochondria within 5 minutes (32,35,36). Once in the cytosol, cytochrome c binds its 
cytosolic partner apaf-\ and induces the oligomerization of apaf-\» cytchrome c complex 
in a dATP/ATP-dependent manner (34,35,39). Apaf-\ is a 130-kDa protein that consists 
of the following three domains: the N-terminal contains 85 amino acids that show 
homology with the prodomain of several caspases including caspase-1, -2 and -9 
(20,21,24,25,28,39). This domain appears to function as the caspase recruitment domain 
(CARD) to bind caspases with a similar CARD (20,21,28). It is of interest that caspase-9 
is the only procaspase of all the CARD-carrying caspases to be activated by apaf-\ (28). 
After the CARD domain follows a stretch consisting of 310 amino acids that have 50% 
homology to the C. elegans death promoting domain ced-A (20,21,28,39). The most
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obvious conserved regions of this domain are the Walker’s A and B boxes, which are 
believed to be necessary for nucleotide binding since mutations in this nucleotide-binding 
site abolish both apqf-\ and ced-4 function (20,21,28,39). The ATP synthase complex 
contains alpha- and beta-subunits (A and B subunits), which binds ATP and ADP 
(33,34,38). The beta subunit contributes to the catalytic sites whereas the alpha subunit 
appears to be involved in the regulation of the ATP synthase activity (40). Amino acid 
sequences of alpha-and beta-subunits are weakly homlogous to each other and may have 
common functions in catalysis (40). Related sequences in both, alpha- and beta-subunits 
as well as other enzymes that bind ATP and ADP, have helped to identify regions 
contributing to an adenine nucleotide binding fold in both ATP synthase subunits (40). 
The C-terminal half of apaf-l contains 12-13 WD-40 repeats that mediate protein-protein 
interactions (20,21,22,28,39). WD-40 repeats are highly conserved repeating units found 
in all eukaryotes usually ending with residues WD (41). A truncated apqf-\, in which the 
WD-40 repeats have been removed, renders apaf-\ constitutively active in vitro, 
independent of dATP/ATP and cytochrome c (28,38,39). Conversely, activated caspase- 
9 cannot be released from apqf-\ when the WD-40 repeats are truncated, signifying that 
this domain normally fulfills dual functions to inhibit apaf-\ activity and to help release 
the activated caspase-9 (20,28,37). The critical role of apqf-\ was confirmed by the 
analysis of upqf-l-deficient mice displaying abnormalities in several tissues, particularly 
the brain, as well as lack of developmental cell death (20,24,42). On the transcriptional 
level, the regulation of apaf-\ha& been implicated in several important biological 
processes particularly in tumorigensis and during the development of the mammalian 
central nervous system (43). Apqf-\ has been described to be the core of the apoptosome
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and cytochrome c, which is essential for mitochondrial respiration and energy production 
and fonctions as a cofactor in the activation of caspases (42). All four components, 
cytochrome c, apaf-l, dATP/ATP and procaspase-9, form the apoptosome complex 
(18,21,22,28,37,39,42,43).
Cytochrome c is pivotal to the apoptosome assembly. Cell lines lacking cytochrome 
c and grown under conditions that mitigate the loss of this electron carrier, failed to form 
an apoptosome and failed to activate procaspase-9 in response to proapoptotic stimuli 
(39). Mitochondrion-dependent apoptosis requires activation of procaspase-9 to initiate 
the caspase cascade (37,45). This activation is dependent on the protein apaf-l, which 
has to be activated by cofactors cytochrome c and dATP (45). Cytochrome c binds cq?af- 
1 strongly in the absence of dATP; however, addition of dATP to the cytochrome c»apaf- 
1 complex results in further assembly producing a larger complex made up of 8-10 apqf-l 
molecules along with associated cytochrome c molecules (23,45). Fluorescence 
polarization, ECL (enhanced chemiluminescence) and acrylamide fluorescence 
quenching results show the stoichiometry of this complex to be 2 cyt c  1 apaf-l and has 
been shown not to change with the addition of dATP (45). The role of dATP is to assist 
formation of the apoptosome complex (23,45). Apaf-l alone binds dATP poorly and in 
the presence of cytochrome c, nucleotide binding of apaf-l increases about 10-fold, 
confirming the temporal sequence of binding events that take place (23,37).
Furthermore, procaspase-9 increases dATP binding to apqf-l indicating that the 
formation of the apoptosome is a synergistic event that stabilizes nucleotide binding (37). 
The stoichiometry of apaf-l and procasase-9 binding is believed to be 1:1 due to the 
observed CARD:CARD interactions (20,28). The assumption is that procaspase-9
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autodigests at cfpaf-\ and cleaves a neighboring procaspase-9 to form a tetramer; thus, the 
activated caspase is formed (20). Lastly, activated caspase-9 is released from the 
apoptosome and goes on to cleave and activate downstream caspases such as 
procaspases-3, -6, and -7 (28). Specific target substrates are then cleaved leading to 
apoptosis (18).
The apoptosome complex has been isolated and found to exist in two different sizes. 
There is one -1 .4  MDa complex that appears to be inactive and may be due to 
inappropriate oligomerization of the apaf-\ (20,21,27). Then there is an -  700 kDa 
complex that is capable of processing and activating effector caspases. It is this complex 
that has been found to be primarily assembled during apoptosis (20,21). The structure of 
the apoptosome has been hypothesized to be a wheel-like particle with seven spokes that 
radiate from a concave, central hub (39). The hub and bent spokes combine to give the 
apoptosome a puckered shape (39). Acehan et al. suggest in this model that cytochrome 
c interacts with WD-40 repeats that are contained in the spokes, place apaf-\ in the upper 
region of the hub and have dATP binding to the ced~A homology region of the apaf-\ 
with procaspase-9 being tethered to the apoptosome via CARD CARD interactions (39).
Electron Carriers
Several electron carriers participate in the mitochondrial electron transport chain (Fig. 
3, p. 28) (33,34,44).
Complex I contains the NADH-coenzyme Q reductase (33,34,44). Nicotinamide 
adenine dinucleotide (NAD^ is a major electron acceptor in oxidative (catabolic) 
pathways (33,34). It is involved in hydride anion transfer either to NAD^ or from NADH
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
19
(the reduced form) and because the hydride anion contains two electrons, acts solely as a 
two-electron carrier (33). NADH binds to the enzyme on the matrix side of the inner 
mitochondrial membrane and transfers its electrons to tightly bound flavin 
mononucleotide (FMN) (33). FMN belongs to the flavin coenzymes, can participate in 
one- and two-electron transfers and is a stronger oxidizing agent than NAD^ (33).
FMNH2 then transfers electrons to a series of Fe-S proteins, which results in the two- 
electron transfers to coenzyme Q (33,34,44). Coenzyme Q is also known as ubiquinone, 
CoQ or UQ (33). It owes it hydrophobicity to its isoprenoid tail, which allows it to freely 
diffuse in the inner mitochondrial membrane (33). This allows the shuttling of electrons 
between Complex I, II and HI (33).
In Complex II, succinate dehydrogenase contains two Fe-S proteins, flavoprotein 2 
that has an FAD covalently bound to a histidine residue and three Fe-S centers. FAD is 
reduced to FADH2 .
Complex m , CoQ- cytochrome c reductase, has three different cytochromes and one 
Fe-S protein. The cytochromes are: b cytochrome (Z>Land Z>h) and c  cytochrome. They 
are one- electron carriers. It is only cytochrome c that transfers one electron at a time 
from Complex III to Complex IV (33). Electrons traveling through Complex III are 
passed through cytochrome Ci to cytochrome c (33,34). Cytochrome c is the only 
watersoluble one of the cyochromes and like UQ a mobile electron carrier. It associates 
loosely with the inner mitochondrial membrane, in the IMS on the cytosolic side of the 
inner membrane, to aquire an electron from the Fe-S-cyt Ci aggregate of Complex III 
(33,34). It migrates from Complex III along the membrane surface in the reduced 
state to Complex IV (33,34).
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Complex IV, Cytochrome c Oxidase, consists of cytochrome c a and as as well as two 
copper atoms. The reduction of molecular oxygen to water is accomplished here.
In summary, the major electron carriers of the respiratory chain are: NADH, 
coenzyme Q, cytochrome c and FAD. Table 2, page 25, shows their standard reduction 
potentials.
Cancer
Cancer has two characteristics. One is uncontrolled cellular proliferation and the 
other is the failure of cells to undergo apoptosis (43). Normally, cells develop a specific 
morphology and function, which is known as differentiation (8). The process of 
differentiation causes normal cells to lose their ability to proliferate (8). This process is 
kept in balance through the replacement of less-mature precursor cells also known as 
stem cells in renewal tissue (44). Precursor cells then go on to differentiate and it is fi'om 
these precursor cells that cancer most likely originates (8). Evidence points to the 
transformation of a single precursor cell that proliferates to form a clone since all cells in 
a tumor appear to share some particular characteristic(s) of the original precursor cell (8).
Cancer cells are defined by two properties. The first property is that they and their 
progeny reproduce without regard of normal constraints; the second property is that they 
invade and colonize areas that are needed by other cells (44).
Out of control proliferation gives rise to a tumor, or neoplasm, which can either stay 
clustered or can invade surrounding tissue. The ability to invade other tissue depends on 
the ability to break loose, enter the bloodstream or lymphatic vessels, and form secondary 
tumors, or metasteses (44,8). There are several mechanisms that ensure that cell
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proliferation does not exceed the needs of a normal tissue. To name a few, there is 
promotion of cell differentiation by tumor suppressor genes, limitation of the total 
number of cell generations before senescence and apoptosis (46). Numerous normal 
developing tissues eliminate improperly developing cells by initiating apoptosis (46).
The p53 gene, which is a tumor suppressor gene, appears to play a regulatory role in 
apoptosis (46). Activated p53 functions as transcriptional transactivator, transrepressor 
and participates in numerous protein-protein interactions (46). The ability of p53 to 
transcriptionally activate apaf-\ has been shown in mitochondria-induced apoptosis (46). 
Furthermore, activated p53 regulates the expression of genes that are in control of the 
mitochondrial membrane permeability, hence, the release of cytochrome c (46). Two 
sites in the apaf-\ promoter relative to the transcriptional start site were found to 
correspond to a p53-responsive element and a radiolabeled apaf-\ wild-type 
oligonucleotide containing the p53-responsive element was shown to bind p53 (46). A 
mutation in this gene, resulting in loss of function, prevents the physiological crucial 
elimination of unneeded cells (46). The p53 gene has been found inactivated in several 
neoplasms (47).
As has been described thus far, the molecular pathways that lead to the activation of 
caspases are tightly regulated. This regulation can be interfered with at the level of 
HSPs. The role of HSP27 in the inhibition of apoptosis has been investigated. It has 
been found that cytosolic HSP27, in human leukemic cells, interacts with cytochrome c 
released from the mitochondrial IMS, therefore inhibiting apoptosome formation as well 
as caspase activation (5). It was shown by Garrido et al. that in a cell free system, HSP27 
co-immunoprecipitated with cytochrome c and not with procaspase-9, apqf-l or
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procaspase-3 (5). The protection that HSP27 gives to cells against apoptosis aids the 
survival of cancerous cells.
Hypothesis
The purpose of this study is to investigate if the electron carriers, cytochrome c, FAD, 
NADH, Qio and one component, ATP, of the mitochondrial electron transport chain have 
any cytotoxic effects on various cell lines. Treatments with these electron carriers and 
ATP will be applied in increasing concentrations. The main goal is to see if HSP27 can 
provide protection against these agents. The first hypothesis of this study is that 
mitochondrial electron transport carriers and ATP can reduce cell proliferation in human 
cell lines. The second hypothesis is that HSP27 can protect human breast cancer cells 
against the toxic effects of these electron carriers and ATP.
The techniques used to achieve these goals are clonogenic survival assays and 
Western blotting analysis.
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Table I
Alphabetical list o f amino acid abbreviations
One-letter Symbol Tliree-letter Abbreviation Amino Acid
A Ala Alanine
B Asx Asparagine or Aspartic acid
C Cys Cysteine
D Asp Aspartic acid
E Glu Glutamic acid
F Phe Phenylalanine
G Gly Glycine
H His Histidine
I He Isoleucine
K Lys Lysine
L Leu Leucine
M Met Methionine
N Asn Asparagine
P Pro Proline
Q Gin Glutamine
R Arg Arginine
S Ser Serine
T Thr Threonine
V Val Valine
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Table I (continued)
Alphabetical list o f amino acid abbreviations
One-letter Symbol Three-letter Abbreviation Amino Acid
W Trp Tryptophan
Y Tyr Tyrosine
Z Glx Glutamine or Glutamic acid
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Table H
Standard reduction potentials o f the four major electron carriers o f the respiratory chain
Oxidant Reductant Transferred e" E'.(V)
Cytochrome c Cytochrome c 1 + 0.254
CoQ (oxidized) CoQ (reduced) 2 + 0.060
FAD^ FADH2 2 -0.219
NAD^ NADH + I f 2 - 0.320
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Fas Ligand
Fas receptor
DISC
(Death Inducing Signaling Complex)
FADD/Mort 1
Daxx
Procaspase-8Caspase-8
HSP27
Procaspase-3
1
Procaspase-7 £7'''^C>Caspase-7 INK
(1-Jun N-Terminal Kinase)
Nuclear Substrates
Apoptosis
FIG. 1 Death receptor apoptosis. Binding of FasL (Fas/CD95 ligand) to Fas receptor 
induces trimerization of Fas. The death domain-containing (DD-containing) adaptor molecule, 
FADD/Mort 1, contains a DD at its C-terminus, is recruited to the cytoplasmic region of Fas and 
binds to the DD of Fas forming death-inducing signaling complex (DISC). The N-terminus of 
F ADD is needed for recruiting initiator procaspase-8 and/or procaspase-10. Procaspase-8 has 
two death effector domains (DEDs) at its N-terminal region where it binds F ADD Procaspase-8 
autoactivates at the DISC, then activates procaspase-3, which is the procaspase that death 
receptor and mitochondrion-dependent apoptosis pathways converge on. Daxx can associate with 
the Fas receptor and activate the INK apoptotic pathway.
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Outer Membrane
Inner Membrane Mitochondrial
Matrix
Intermembrane space
Apoptosome 
Apaf-i 
C\1ochrome c 
dATP 
Procaspase-9 HSP27
Caspase-9
Procaspase-3
Caspase-3
Nuclear Substrates
Procaspase-7
Caspase-7 Apoptosis
FIG. 2 Mitochondrion-dependent apoptosis. In response to apoptotic stimuli the 
mitochondrion releases cytochrome c, caspases, AIF (apoptosis-inducing factor), and 
SMAC/Diablo (second mitochondria-derived activator of caspases and murine homologue) into 
the cytosol to trigger caspase activation. In the cytosol cytochrome c is essential to the 
apoptosome, which consists of apaf-\, dATP and procaspase-9. Procaspase-9 autoactivates at the 
apoptosome, then cleaves procaspase-3, which cleaves procaspase-7, which cleaves specific 
target substrates leading to apoptosis. The binding of HSP27 to cytochrome c prevents the 
formation of the apoptosome; therefore inhibiting apoptosis.
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Intermembrane Space
Cxiochrome c (ox.)
2FT2 l f Cxtochrome c (red.)
2 Fe-S lit
Complex ComplexComplex Complex
2H
FMNH;
FAD
FMN'
2«r
2H"NAD^ NADH + H Succinate Fumarate
0  +2IC
Matrix space
FIG. 3 The mitochondrial electron transport chain (respiratory chain). Four distinct 
protein complexes make up the mitochondrial respiratory chain: (I) NADH-coenzyme Q 
reductase, (II) succinate-coenzyme Q reductase, (HI) coenzyme Q-cytochrome c reductase, and 
(IV) cytochrome c oxidase. NADH donates electrons to Complex I, serving as a link between 
glycolysis, the TCA cycle, fatty acid oxidation and the electron transport chain. Complex I and II 
produce a common product, reduced coenzyme Q (UQH2), which becomes the substrate for 
Complex III. Complex HI oxidizes UQH2 and reduces cytochrome c, which is the substrate for 
Complex IV and this is where molecular oxygen is reduced to water.
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Table HI
Glossary
Terms Definitions
AIF
Apaf-l
Apoptosis
Apoptosome
Ask 1
CARD
Caspase
Caspase - 3
Caspase - 7
Caspase - 8 
Caspase - 9 
Daxx
Apoptosis inducing factor
Apoptotic protease activating factor-1
Programmed cell death
A complex whose assembly is central to 
the activation of apoptosis. It consists of 
Apaf-l, holo-cytochrome c (containing the 
heme group), dATP/ATP and procaspase- 
9.
Apoptosis signal-regulated kinase 1
Caspase recruitment domain
Cysteinyl aspartic acid - protease 
(recognizes aspartic acid residues and cuts 
at those sites).
A cysteinyl aspartic acid -  protease that is 
cleaved by caspase - 9 and is part of the 
mitochondrion dependent apoptotic 
pathway.
A cysteinyl aspartic acid - protease that 
cleaves essential nuclear substrates, 
completing apoptosis.
A cysteinyl aspartic acid - protease 
involved in receptor - mediated apoptosis.
A cysteinyl aspartic acid - protease that 
self-activates at the apoptosome.
Daxx is a Fas receptor binding protein and 
can activate the INK apoptotic pathway.
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Table m  (continued)
Glossary
Terms Definitions
DD Death domain
DED Death effector domain
DISC Death inducing signaling pathway
ECL Enhanced chemilunescence
FADD Fas associated death domain
Fas Fas is a member of the TNF (Tumor 
necrosis factor) receptor family. It is 
involved in receptor mediated apoptosis.
FasL Fas ligand binds to Fas
HRE Hormone response element
HSP Heat shock protein
IMS Intermembrane space
MAPKAP Mitogen-activated protein kinase-activated 
protein
NK Natural killer cells
POD PML-oncogenic domain
p38MAP Mitogen-activated protein
ROS Reactive oxygen species
SAPK1/JNK Stress-activated protein kinase 1-Jun N- 
terminal kinase
sHSP Small heat shock protein
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Table IQ (continued)
Glossary
Terms Definitions
SMAC/Diablo Second mitochondria-derived activator of 
caspases and murine homologue
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
CHAPTER 2
MATERIALS AND METHODS 
Cell Lines
Four human breast cancer cell lines (DC4, DB46, MCF-7 & MDA-MB-435), one 
human colon cancer cell line (RKO) and one “normal”, human lung fibroblast cell line 
(HFLl) were used. RKO and HFLl were a kind gift fi'om Dr. R. Gary (UNLV). DC4 & 
DB46 were derived from an estrogen-receptor negative human breast cancer cell line 
MDA-MB-231 (7). DB46, which has the constitutive expression vector pP27, expresses 
elevated levels of heat shock protein 27. The vector was constructed by cloning an 
EcoRI cDNA fragment of HSP27 into the SaE site of pH^Apr-l-neo by a blimt end 
ligation after filling in the fragments (48). DC4, which is the control, contains only the 
vector pHPApr-l-neo; therefore, it expresses basal levels of heat shock protein 27 (7). 
MCF-7 has cytoplasmic estrogen receptors and MDA-MB-435 does not (9). All cell 
lines were grown in Minimal Essential Media (MEM), supplemented with 10% fetal 
bovine serum, 25 mM HEPES buffer (pH 7.4), 100 lU penicillin/ml, 100 gg/ml 
streptomycin, 2 mM L-glutamine, and for DC4, DB46 cell lines, 400 gg/ml G418 sulfate. 
RKO was supplemented with 1.0 mM sodium pyruvate. All reagents used in cell culture 
were purchased from Gibco BRL, Grand Island, NY. All cell lines were maintained in 
humidified incubators at 37°C with 5% CÜ2:95% air. Forty-eight hours before an
32
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experiment the cell lines, DC4 & DB46, were washed and resuspended in supplemented 
MEM lacking G418.
Electron Carriers and Reagents 
The following electron carriers and reagents were purchased from Sigma: 
cytochrome c, Qio, DMSO, FAD, P-NADH and ATP. MgClz'ZHzO was obtained from 
Fisher Scientific.
Cytochrome c was suspended in 5 ml of PBS (phosphate buffered saline, pH 7.2,
(IX), no Mg^ ,^ no Ca^^) from which serial dilutions were made to yield experimental 
concentrations (PBS was purchased from Gibco BRL). FAD, P-NADH, ATP and MgCL 
were suspended in 10 ml of PBS from which dilutions were made. MgCL was used as a 
control in the ATP experiment. It was used at 1x10*’ M, which was the highest 
experimental concentration of ATP utihzed. Qio was suspended in heated DMSO. A 500 
ml beaker was filled with 200 ml of water so that a 15 ml centrifuge tube containing 
DMSO and Qio can be submerged halfway. First the water was heated for one minute in 
a microwave on high power. After removing the beaker from the microwave the 15 ml 
centrifuge tube was submerged halfway for 15 seconds at a time (3x). After each 
submersion the 15ml centrifuge tube was vortexed. After the third vortex Qio was 
dissolved. DMSO was used as a control in the following molarities: 276 mM,
138 mM, 27.6 mM and 2.76 mM. All reagents and electron carriers were made fresh 
and filter sterilized prior to dilutions.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
34
Heat Shock
Twenty-four hours before the experiment, a water bath was filled with deionized 
water and heated to 45°C ± 0.01°C. A DC4 flask (T-25) was taken under the hood and 
sprayed with a spray bottle containing 70% ethanol and 30% water. Its vented cap was 
replaced with a solid cap and the entire flask was wrapped with parafilm so that no water 
could enter the flask once it was submerged in the water bath. The flask was then 
submerged in the heated water for 10 minutes after which it was removed. Parafilm was 
then removed and paper towels were used to collect any water that might have gotten 
under the cap. The flask was sprayed with again with a 70% ethanol/ 30% water dilution 
and taken under the hood. There the cap was exchanged and secured. The flask was then 
transferred back to the incubator.
Clonogenic Survival
The cell lines were exposed to the above mentioned electron carriers and reagents in 
various concentrations. Each exposure was for one hour at 37°C after which the cells 
were washed once in 5 ml of PBS, trypsinized, resuspended in supplemented MEM and 
counted using a Coulter Counter (Model ZF). Cells were plated in 60 mm tissue culture 
dishes. Each experiment was set up in triplicates. Cells were incubated at 37°C in a 
humidified incubator with 5% C02:95% air for eleven days. After incubation, cells were 
removed from incubator, stained with crystal violet (0.5% Crystal violet:95% ethanol), 
allowed to dry and counted. Colonies consisting of > 50 cells were counted (cells 
survived). Results are graphed as percent survival.
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Western Blotting
For Western blotting, cells from each cell line were trypsinized in T-25 flasks. When 
cells of a cell line were freely floating in trypsin, media was added and the contents of the 
flasks were emptied into a 15 ml centrifuge tube. The cells were centrifuged at 2000 rpm 
for 5 minutes in a Beckman Model TJ-6 Centrifuge at 4°C and the media was drained.
The pellets were resuspended in 1 ml of PBS buffer. A 50 ml beaker was halfway filled 
with ice, the 15 ml centrifuge tube was put into the ice and held under a sonifier micro tip 
for 10 sec (3x) at power 3 (Branson Sonifier 450). The contents were transferred into a 
microfuge tube and spun for 2 min in a Fisher Scientific Micro Centrifuge (Model 235C). 
The supernatant was then transferred into a microfrige tube. 9 pi of the supernatant was 
added to 3 pi of 4x cracking buffer (4x cb), which was then subjected to SDS-PAGE 
(15%). 4x cb consisted of 60% sucrose, lOOmM Tris, 8% SDS, 0.8% bromophenol blue, 
8% 13-mercapto ethanol, which was adjusted to pH 6.8 with HCL. The SDS-PAGE was 
electrophoresed at 40 mAmps for 40-45 min. The resolved proteins were then 
electroblotted onto a PDVF membrane in Western transfer buffer Ix at a constant 25 mV 
for I hr. Ix Western transfer buffer consisted of 12 mM trizma, 96 mM glycine in 800 ml 
water and 200 ml ethanol. The membrane was blocked with 10% non-fat dry milk 
(Carnation®) in Ix Western wash (40 ml total volume) and rocked for one hour at room 
temperature (R. T.) Ix Western wash was obtained from lOx Western wash. lOx 
Western wash consisted of lOx TBS and 0.1% Triton x-100. lOx TBS consisted of 0.5 M 
trizma, 1.5 M NaCl which was adjusted to a pH of 7.4 with HCL. Water was added until 
Vtot= 0.5L. Following the blocking, a 1° mouse monoclonal antibody (Ab) against 
HSP27 (Stressgen # SPA-800) was used. 8pi of Ab were dissolved in SOOpl of 10%
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milk, which was put in 7.2 ml of Ix Western wash thus bringing Vtot = 8 ml. After 
removing the blocking agent, the 8 ml Ab solution was added and then rocked in cold 
room (4°C) overnight. After 24 hrs the membrane was rinsed 4x in Western wash 
(volume 20 ml each time) at R. T. The procedure for washing: 5 min rocked, flipped, 5 
min rocked, after which solution was changed. Total time elapsed was 40 min after 
which the 2° Ab Alexa Fluor 532 goat anti-mouse (Molecular Probes # A-11002) was 
added. The volume again was 8 pi of Ab in 800pl of 10% milk put in 7.2 ml of Ix 
Western wash. This was rocked for 1.5 hrs at R.T. after which it was subjected to the 
same washing procedures as the 1° Ab and was stored in Western wash. The sheets were 
then scanned by Typhoon™ 9410. Emission filter was set at 555 BP 20 Alexafluor 532 
and the following settings were used: PMT -  400, laser -  green (532), sensitivity -  
normal, pixel size -  200 microns, focal plane -  platen.
Statistical Analysis
The data is presented as the mean ± S.D.; statistical analysis of variance (ANOVA) 
was performed with the JMP program. In this program, the LS Means Differences 
Student’s t with regard to significance of treatment, cell type and treatment to cell type 
categories were utilized.
Each bar graph in a figure is representative of up to six replicates of 60 mm dishes. 
Error bars are representative of standard deviation.
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CHAPTER 3 
RESULTS
Incubation with Cytochrome c Induces Cell Death 
The mechanism of cytochrome c induced apoptosis has been documented and is 
described in Chapter 1 (Figure 2, p. 27) (5). With this mind, the effects of exogenous 
addition of various cytochrome c concentrations to several cell lines were investigated. 
Breast cancer cell lines DC4, DB46, MCF-7 and MDA-MB-435 were treated with the 
following concentrations of cytochrome c: TO = 0, T1 = 5x 10 ’ M, T2 = 5x10*^  M and 
T3 = 5x10'^ M (Fig. 4, 5, pp. 51, 52). DC4 was heat shocked for this experiment to see if 
more protection from cytochrome c toxicity could be observed. RKO and HFLl were 
treated with the following cytochrome c concentrations: TO = 0, T1 = 5.6x10 *M,
T2 = 5.6x10’M and T3 = 5.6xlO*^M(Fig. 6, p. 53).
DC4, HS DC4 and DB46 cells showed a dose response to T2 and T3 (Figure 4, 
p. 51). Cell survival was most affected in response to T3. HS DC4 survival rate at 44% 
was similar to DB46 at 41%. DC4 survival rate was 18%. Western blotting (Fig. 18 A, 
p. 65) shows the HSP27 expression in DC4 con. (con, = control = not heat shocked), HS 
DC4 (HS = heat shocked, as described in Chapter 2, p. 34), DB46 con. and DB46 HS. 
Relative quantification of the results to 0.1 pg of HSP27 in Western blotting (Fig. 18 A, 
p. 65) resulted in the following values: DC4 con. - 0.053, HS DC4 -1.16, DB46
37
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con. -1.16, HS DB46 - 5.38. From these values it can be seen that HSP27 expression in 
HS DC4 is the same as in DB46 control. This increased level of HSP27 expression in HS 
DC4 gives the cells about the same protection against cytochrome c toxicity as is 
observed in DB46. Control DC4, which shows a very small quantification number of 
HSP27 expression, does not have this protection due to the very low basal levels of 
HSP27 and therefore has a much lower survival rate as mentioned above. HSP27 
expression increases about five-fold in DB46 following heat shock.
MCF-7 and MDA-MB-435 also responded in a dose dependent manner to cytochrome 
c treatments with the highest percent of cells killed at T3 (Fig. 5, p. 52). At T3, MCF-7 
had the highest survival rate of all the breast cancer cell lines with 64.5%, which can be 
explained by constitutive expression of HSP27 in the cell line and MDA-MB-435, which 
does not constitutively express HSP27, had a survival rate of 36%. The treatment 
response of the cells can also be explained by looking at Western blotting (Fig. 18 B, p. 
65). Quantification values are reported relative to 0.1 pg of HSP27 expression in Western 
blotting (Fig. 18 A & B, p. 65) and are as follows: MCF-7 con. -14.56, MCF-7 HS15.07, 
RKO con. - 0.63, RKO HS - 0.44, MDA-MB-435 con. - 0.23, MDA-MB-435 HS - 0.78. 
These values show that, following heat shock, HSP27 expression does not change much 
in the MCF-7 cell line. A reduction of HSP27 expression is observed in the RKO cell 
line following heat shock and about a three-fold increase is seen in the MDA-MB-435 
cell line following heat shock treatment. The difference in HSP27 expression in the two 
breast cancer cell hnes and the resulting survival rates are analogous to the survival rates 
of DC4 and DB46 in the previous experiment. HSP27 protects the MCF-7 cells against 
the cytotoxic effects of cytochrome c and the low levels of HSP27 present in MDA-MB-
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435 are not able to give that protection against cytochrome c toxicity in that cell line.
RKO was not sensitive to any of the cytochrome c concentrations and HFLl was 
sensitive only at the highest cytochrome c concentration T3 with about a 45% cell 
survival (Fig. 6, p. 53). Western blotting (Fig. 18 B, p. 65) shows low HSP27 expression 
in the RKO cell line. Unfortunately, Western blotting could not be done with the HFLl 
cell line because of loss to mold and therefore no data is available with regard to HSP27 
levels in that cell line. It is not clear what mechanism was induced to protect the two cell 
lines against cell death. It is clear that the RKO cell line was much more resistant to 
cytochrome c toxicity than the breast cancer cell lines.
In summary, the survival rates at the highest cytochrome c concentrations are as 
follows: RKO - 100%, HFLl - 55.0%, MCF-7 - 64.0%, HS DC4 - 44%, DB46 - 41%, 
MDA-MB-435 - 36% and DC4 - 18%.
Statistical analyses were performed on the three experiments above to see if there 
were significant differences between treatments, between cell lines and treatment effect 
between cell lines.
A significant effect of cytochrome c treatments (ANOVA, p<0.0001) on mean cell 
survival in each cell line DC4, DB46 and HS DC4 exists (Fig. 4, p. 51). With regard to 
treatment there are no significant differences (LS Means Differences Student’s t, p>0.05) 
between control and Tl. T2 is significantly different (LS Means Differences Students t, 
p<0.0 5) from control, Tland T3. T3 is significantly different fi’om control, Tl and T2. 
Cell type (LS Means Differences Student’s t, p<0.05) differences were significant 
between DC4 and HS DC4 as well as DC4 and DB46. Treatment to cell type (LS Means 
Differences Student’s t, p<0.05) confirms that the DC4 cell line is significantly different
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from HS DC4 and the cell line DB46 and vice versa in response to treatment. 
Furthermore, HS DC4 and DB46 are not significantly different in their response to 
treatment.
A significant effect of cytochrome c treatments (ANOVA, p<0.0001) was seen on 
mean cell survivals across the cell lines MCF-7 and MDA-MB-435 (Fig. 5, p. 52).
Again, with regard to treatment there are no significant differences (LS Means 
Differences Student’s t, p>0.05) between control and Tl. T2 is significantly different 
from control, Tl and T3. Conversely, T3 is significantly different from control, Tl and 
T2. A significant difference across means between cell types was not found (LS Means 
Differences Student’s t, p>0.05). Treatment effects between cell lines showed that only 
T3 on MCF-7 and MDA-MB-435 was significantly different fi-om all other treatments. 
Cytochrome c treatments in RKO and HFLl (ANOVA, p>0.0001) showed no significant 
differences on mean cell survival across these two cell lines (Fig. 6, p. 53). Also no 
significant differences were found between cell types (LS Means Differences Student’s t, 
p>0.05). Finally, the only significant difference was found to exist between T3 in HFLl 
and all other treatments including all treatments with the RKO cell line. The results for 
this experiment show that the cell type and response to treatment are only significantly 
different in the HFLl cell line with regard to T3.
FAD Can Induce Cell Death 
This lab has shown that treatment of breast cancer cell lines with exogenous addition 
of cytochrome c has varying cytotoxic effects among those cell lines. Given that 
cytochrome c is an electron carrier involved in the mitochondrial electron transport chain.
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the decision was made to look at FAD, NADH, Qio as well as ATP, which are the other 
electron carriers and one component that play a role in the mitochondrial electron 
transport chain. The purpose was to use these agents as controls to help show that only 
exogenous cytochrome c treatment can induce cell death. The same cell lines as in the 
previous experiments were used (Fig. 7, 9, 10, pp. 54, 56, 57). DC4 was not heat 
shocked for these experiments.
FAD was applied in the following concentrations: TO = 0, Tl = IxlO'^M, T2 = 1x10'  ^
M and T3 = IxlO'^M. These concentrations are much smaller than the cytochrome c 
concentrations in the previous experiments; yet, FAD was found to be more cytotoxic in 
the DC4, DB46, MCF-7, MDA-MB-435, RKO and HFL-1 cell lines.
The DC4 and DB46 graph (Fig. 7, p. 54) shows a step function in response to FAD 
treatment. DC4 had a survival rate of 30.0% and DB46 had a survival rate of 57.0% at 
T3. Higher cell survival in DB46 is attributed to the elevated levels of HSP27 in that cell 
line.
It was of interest to see what effects FAD would have at the same concentrations as 
cytochrome c and therefore the following concentrations: TO = 0, Tl = 5x10'^ M, T2 = 
5x10"  ^M and T3 = 5x10"  ^M were applied in another experiment involving the cell lines 
DC4 and DB46 (Fig. 8, p. 55). A dose response was observed at these concentrations.
At T2, DB46 had about 16% and DC4 about 13% cell survival. At T3, the cell survival 
of DB46 was almost negligible (0.33%) and DC4 had no survival.
MCF-7 and MDA-MB-435 (Fig. 9, p. 56) were given FAD treatments at the 
following concentrations: TO = 0, T l-  1x10'^M, T2 = 1x10"*M and T3= 1x10'^M. 
MCF-7 and MDA-MB-435 showed similar patterns to FAD treatments when compared
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to DC4 and DB46 responses at these concentrations. MCF-7 has more protection against 
FAD toxicity just like DB46 and MDA-MB-435 this electron carrier in DB46 and MCF-7 
since these two cell lines express high levels of this protein and both behave similarly.
The next experiment regarding FAD toxicity involved the cell lines RKO and HFLl. 
Both cell lines responded to FAD treatments (Fig. 10, p. 57). Survival rates for RKO and 
HFLl at T3 were 75.0% and 61.0%, respectively. It not clear what gave RKO protection 
against FAD toxicity since the Western blotting results did not show high levels of 
HSP27 in that cell line.
A summary of dose responses observed in all cell lines and the survival rates at the 
highest FAD concentration (T3) are as follows; RKO - 75.0%, MCF-7 - 64.0%, HFLl- 
61.0%, DB46 - 57.0%, MDA-MB-435 - 41.0% and DC4 - 30.0%.
Again, statistical analyses were performed on the four experiments above to see if 
there were significant differences between treatments, between cell lines and treatment 
effect between cell lines.
A significant effect of FAD treatments (TO = 0, Tl = 1x10'  ^M, T2 = 1x10'* M and 
T3 = IxlO'^M) (ANOVA, p<0.0001) on mean cell survival across the cell lines DC4 and 
DB46 exists (Fig. 7, p. 54). Results of treatment analysis (LS Mean Differences 
Student’s t, p<0.05) show Tl, T2 and T3 being significantly different from TO. 
Furthermore, Tl and T2 are not significantly different from one another but T3 is 
significantly different from T2. Significant differences were found between cell lines 
DC4 and DB46 (LS Mean Differences Student’s t, p<0.05). Results from treatment to 
cell type analysis (LS Mean Differences Student’s t, p<0.05) revealed that the significant
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differences exist between the cell lines and treatment and not within the cell lines and 
treatment, thus the two cell lines respond differently to FAD treatment.
Highly significant effects of FAD treatments (TO = 0, Tl = SxlO'^M, T2 = 5x10"  ^M 
and T3 -  5x10'^ M) (ANOVA, p<0.0001) on mean cell survival across the cell lines DC4 
and DB46 exist (Fig. 8, p. 55). Results of treatment analysis (LS Mean Differences 
Student’s t, p<0.05) show Tl, T2 and T3 to be significantly different from one another as 
well as from TO. Also significant differences exist between the cell lines (LS Mean 
Differences Student’s t, p<0.05) and finally treatment to cell type analysis (LS Mean 
Differences Student’s t, p<0.05) shows that both cell lines respond with a similar pattern 
to treatment, thus significance lies in the treatment.
In the MCF-7/MD A-MB-435 experiment significant effects of FAD treatments (TO = 
0, T2 = IxlO'^M, T3 = lxlO‘*M and T4 = IxlO '^M) (ANOVA, p< 0.0001) on mean cell 
survival across the cell lines exist (Fig. 9, p. 56). Treatment analysis (LS Mean 
Differences Student’s t, p<0.05) shows Tl, T2 and T3 to be significantly different from 
TO. Tl and T2 are not significantly different fi'om one another but T3 is significantly 
fi-om Tl. The cell type (p<0.05) is significantly different and analysis of treatment to cell 
type (LS Mean Differences Student’s t, p<0.05) shows significant differences between 
the cell lines with respect to treatment.
Significant effects regarding FAD treatments (TO = 0, Tl = 1x10'® M, T2 = 1x10’* M 
and T3 = IxlO'^M) (ANOVA, p<0.0001) on mean cell survival across the cell lines RKO 
and HFLl exist (Fig. 10, p. 57). Treatment analysis (LS Mean Differences Student’s t, 
p<0.05) shows Tl, T2 and T3 to be significantly different fi-om TO, but Tl, T2 and T3 are 
not significantly different from one another. An analysis of cell type (LS Mean
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Differences Student’s t, p<0.05) shows that the cell types are significantly different.
Finally, treatment to cell type (LS Mean Differences Student’s t, p<0.05) shows that the 
significance of treatment is between not within the cell lines.
ATP Can Affect Cell Survival 
FAD cytotoxicity was not an anticipated outcome of the above experiment. ATP 
consists of an AMP moiety and two attached phosphates. FAD and ATP both have an 
AMP moiety. Upon this observation the decision was made to use ATP in this 
experiment. The same experimental concentrations as in the FAD experiment were 
applied. MgCh was used as a control to make certain it did not induce cell death. The 
concentration for MgCla was 1x1 O’’ M and results showed that it did not have any effect 
on the cells (Fig. 11, p. 58).
DC4 and DB46 were the only cell lines used in this experiment given the trend of 
similar cell survivals among the breast cancer cell lines and keeping in mind that the 
research is pertaining to the effects of electron carriers with regard to breast cancer 
research (Fig. 12, p. 59). Cell survivals for DC4 at increasing concentrations from 
TO = 0, Tl= 1x10’^ M, T2 = 1x10’*M to T3 = 1x10’’ M were 100%, 50.6%, 55.0% and 
52%, respectively. For DB46 the survival rates at the same increasing concentrations 
were 100%, 52.0%, 61.0% and 63.0%, respectively. These results showed a response to 
ATP treatments.
Statistical analysis was performed on the experiment above to see if there were 
significant differences between treatments, between cell lines and treatment effect 
between cell lines.
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Significant effects regarding ATP treatments (TO = 0, Tl = 1x10’^ M, T2 = 1x10'*M 
and T3 = 1x10'’ M) (ANOVA, p<0.0001) on mean cell survival across the cell lines DC4 
and DB46 exist (Figure 12, p. 59). Once again treatment analysis (LS Mean Differences 
Student’s t, p<0.05) shows Tl, T2 and T3 to be significantly different from TO but no 
significant differences exist between Tl, T2 and T3. The cell types are not significantly 
different with respect to their means in this experiment (LS Mean Differences Student’s t, 
p>0.05) and finally analysis of treatment to cell type (LS Mean Differences Student’s t, 
p>0.05) shows the cell types are not significantly different and the treatments do not elicit 
significantly different responses of the cell lines.
NADH Can Induce Cell Death
Since FAD and cytochrome c are able to induce cell death and are both electron 
carriers, we were interested in the toxicity of another electron carrier. NADH, like FAD 
has an AMP moiety attached to its structure. The concentrations applied were again 
TO = 0, T l -  IxlO'^M, T2 -  1x10'*M and T3 = IxlO ’ M.
NADH did have an effect on the cell lines DC4 and DB46 (Fig. 13, p. 60). At T3 cell 
survival for DC4 and DB46 were 38.0% and 40.0% respectively. Interestingly Tl cell 
survival for DC4 was 27% followed by T2 with 52% cell survival.
The RKO cell line responded to NADH treatment with the following percent 
survivals: TO - 100%, Tl - 117%, T2 - 124% and T3 - 103%, thus cell proliferation not 
cell death was the outcome of treatment with this electron carrier. HFLl showed a non­
significant dose response as concentrations were increased with a 71.0% cell survival at 
T3 (Fig. 14, p. 61).
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Statistical analyses were performed on the two experiments above to see if there were 
significant differences between treatments, between cell fines and treatment effects 
between cell fines.
Significant effects regarding NADH treatments (TO- 0 ,  T l -  IxlO'^M, T2 -  1x10^
M and T3 = IxlO ’ M) (ANOVA, p<0.0001) on mean cell survival across the cell lines 
DC4 and DB46 exist (Fig. 13, p. 60). Significances of treatments (LS Mean Differences 
Student’s t, p<0.05) are not between Tl, T2 and T3 but rather between the three 
treatments with respect to TO. The cell fines are not significantly different in their means 
(LS Mean Differences Student’s t, p>0.05) and treatment to cell type analysis (LS Mean 
Differences Student’s t, p<0.05) shows to have significance within the cell fine DC4 (T2 
with respect to TO and Tl) but no significant effects of treatments between or within the 
cell fines DC4 and DB46.
Significant effects regarding NADH treatments (TO -  0, Tl -  1x10'  ^M, T2 -  
IxlO'^M and T3 -  Ix IO ’ M) (ANOVA, p>0.0001) on mean cell survival across the cell 
fines RKO and HFLl do not exist (Fig. 14, p. 61). The cell fines are significantly 
different (LS Mean Differences Student’s t, p<0.05). An analysis of treatment to cell 
type (LS Mean Differences Student’s t, p<0.05) shows that there is a significant 
difference between the cell fines RKO and HFLl in T2 and T3 but no significant 
differences within the RKO cell fine. Significant differences within a cell fine are only 
found in HFLl between Tl and T3. In summary this shows that the cell fines are 
significantly different and treatment significance Avithin the cell fine is between T3 and 
Tl (HFLl) whereas between the cell fines the significance is between T2 in RKO and T2, 
T3 in HFLl and Tl in RKO and T3 in HFLl.
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Qio May Induce Cell Death 
The last electron carrier of the electron transport chain left to investigate was Qio. 
DMSO was used as a solvent for Qio as described in Chapter 2 (Materials and Methods, 
p. 33) and was found not to affect cell survival (Fig. 15, p. 62).
Following this observation, Qio, which was dissolved in DMSO, was applied in the 
same concentrations as in the above experiments; TO = 0, Tl -  1x10"^M, T2 = IxlC^M 
and T3 = 1x10 ’ M. DC4 and DB46 displayed cell death only at T3 with cell survival 
rates of 53.0% and 74.0% respectively (Fig. 16, p. 63). RKO and HFLl were both 
resistant to all of the concentrations applied (Fig. 17, p. 64).
Statistical analyses were performed on the two experiments above to see if there were 
significant differences between treatments, between cell lines and treatment effect 
between cell lines.
Significant effects regarding Qio treatments (TO = 0, Tl = 1x10'^M, T2 = IxlO'^M 
and T3 = 1x10"’ M) (ANOVA, p>0.0001) on mean cell survival across the cell lines DC4 
and DB46 exist only between T3 relative to TO, Tl, T2. No significant differences were 
found between TO relative to Tl or T2, Tl relative to TO or T2 and T2 relative to TO or 
Tl. The means of cell lines are not significantly different (LS Mean Differences 
Student’s t, p>0.05). An analysis of treatment to cell type (LS Mean Differences 
Student’s t, p>0.05) shows that there are no significant differences within or between the 
cell lines DC4 and DB46 with respect to different concentrations except for the following 
two observations. T2 to T3 within the DB46 cell line, T3 between cell lines DC4 and 
DB46 as well as within the cell line DC4 with respect to TO, Tl and T2. In summary, 
this shows that the cell lines and treatment are not significantly different except for T3.
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Significant effects regarding Qio treatments (TO = 0, Tl = 1x10'^M, T2 = 1x10'* M 
and T3 = 1x10'’ M) (ANOVA, p>0.0001) on mean cell survival across the cell lines RKO 
and HFLl do not exist. The means of cell lines are not significantly different (LS Mean 
Differences Student’s t, p>0.05). An analysis of treatment to cell type (LS Mean 
Differences Student’s t, p>0.05) shows that there are no significant differences within or 
between the cell lines RKO and HFLl. In summary, the results of the analyses show that 
the cell lines and treatment do not respond significantly different.
Table IV (p. 49) is a summary containing the responses of the cell lines after 
treatments with the various agents that were used in the above experiments. The results 
of cytochrome c toxicity were taken fi-om this table and compiled (Fig. 19, p. 66). A 
trend line shows that the higher the level of HSP27 expression is in a breast cancer cell 
line the more protection is provided against electron carrier cytotoxicity. It is not clear 
what mechanism of protection is present in the RKO cell line since the level of HSP27 
expression is not enough to provide the observed protection. The results of FAD toxicity 
(Fig. 20, p. 67) show the same trend in these cell lines. Again, it is not clear what 
mechanism of protection is present in the RKO cell line. The breast cancer cell lines 
behave consistently in that the higher the levels of HSP27, the more protection is 
provided against a toxic agent. It is important to mention here that the concentrations of 
FAD were much lower than those of cytochrome c (Table IV, p. 49) and therefore 
showing FAD to be more toxic than cytochrome c.
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Table IV
Toxicity Summary
Agent Cell Line Concentration
(M)
Cell Survival 
(%)
Level of 
Toxicity
Cytochrome DC4 5x10^ 18.0 ****
c HSDC4 5x10^ 44.0 ***
DB46 5x10^ 41.0 ***
MCF-7 5x10': 64.0 **
MDA-MB-
435
5x10-: 36.0 ***
RKO 5.6x10-* 100.0 -
HFLl 5.6x10* 55.3 **
FAD DC4 5x10^ 0 ****
DB46 5x10": .33 ****
DC4 IxlO’ 34.0 ***
DB46 IxlO’’ 57.0 **
MCF-7 1x10'’ 64.0 ***
MDA-MB-
435
IxlO’ 41.0 ***
RKO IxlO’ 75.0 *
HFLl IxlO’ 61.0 ***
ATP DC4 1x10"’ 52.0 ***
DB46 IxlO’ 63.0 ***
Qio DC4 1x10'’ 53.0 ***
DB46 IxlO’ 74. *
RKO IxlO’ 98.0 -
HFLl IxlO’ 102.0 -
- - n o  cell death 
* -  100% - 70% cell survival 
** -  69% - 50% cell survival
*** -  49% - 30% cell survival 
**** — 29% - 0% cell survival
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Table IV (continued)
Toxicity Summary
Agent Cell Line Concentration
(M)
Cell Survival 
(%)
Level of 
Toxicity
DMSO DC4 .276 99.0 _
DB46 .276 99.0
- = no cell death
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FIG. 4. Cytochrome c toxicity observed in DC4, HS DC4 and DB46 cell lines. 
Increasing concentrations of cytochrome c elicit a dose response (lowest percent survival at 
highest concentration) in DC4, HS DC4 and DB46. (Different letters indicate significantly 
different means p<0.05). In this experiment no significant differences were found between 
treatments TO (Control) and Tl (5x10^ M) in all cell lines, hence letters a,d,g are assigned to both 
treatments. In DC4, T2 (5x10"* M) and T3 (5x10'  ^M) are significantly different from TO as well 
as each other; hence letters b and c are assigned. In HS DC4, T2 and T3 are significantly 
different from TO as well as each other, therefore letters e and f  are assigned. In DB46, T2 and 
T3 are significantly different from TO and as well as each other, which are indicated with the 
letters h and i. The assigmnents of letters also show that treatments in relation to cell type have 
significant differences. DC4 was more sensitive to cytochrome c to treatments. HS DC4 and 
DB46 showed similar responses to T2 and T3, thus the cell lines DC4 and DB46 respond 
differently to treatments in this experiment. (No error bars are in DC4 TO, because all but one 60 
mm dish was lost to mold contamination. Experiment was performed twice with similar results.)
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FIG. 5. Cytochrome c toxicity observed in cell lines MCF-7 and MDA-MB-435. A 
dose response is observed in both cell lines with the most cell kill at the highest concentration. 
MCF-7 was less sensitive to cytochrome c treatments than MDA-MB-435. (Different letters 
indicate significantly different means, p<0.05). No significant differences were found between 
TO (Control) and Tl (5x10'  ^M) in both cell lines as letters a and d indicate. Significant 
differences in MCF-7 are between TO, T2 (5x10^ M) and T3 (5x10'  ^M) as shown by letters b and 
c. Significant differences in MDA-MB-435 are between TO, T2, T3 indicated by letters e and f. 
Cell type to treatment response (LS Means Differences Student’s T, p<0.05) revealed that the cell 
lines MCF-7 and MDA-MB-435 responded differently only to T3 otherwise no significant 
differences to treatment responses were found between cell types.
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HRKO 
□  HFL-1
0 5.6x10-8 5.6x10-7 5.6x10-6
[Cytochrome c] = M
FIG. 6. Cytochrome c effects observed in cell lines RKO and HFLl. No significant 
differences on mean cell survival were found across the cell lines (p>0.05) as indicated for RKO 
with letter a and HFLl with letter b. RKO is resistant to all concentrations of cytochrome c. 
HFLl is sensitive to cytochrome c only at the highest concentration. The only significant 
difference was found in HFLl with regard to T3 and the other treatments in that cell line. With 
the exception o f T3 (HFLl) no significant differences were found to exist between cell types and 
treatment response.
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FIG. 7. FAD toxicity observed in DC4 and DB46 cell lines. All concentrations have an 
effect on both cell lines. This experiment shows a step function as response to cytochrome c 
treatments in both cell lines. DC4 is more sensitive to FAD treatments than DB46. The highest 
concentration of FAD yields 70% cell death in DC4 and 48% cell death in DB46. (Different 
letters indicate significantly different means, p>0.05) Significant differences were found between 
TO (control) and all three treatments but no significant differences were found within (p>0.05) the 
cell lines between treatments Tl (IXIO'^M), T2 (IXIO'^M) and T3 (IXlO^M). A significant 
effect of cell type to FAD treatments response (p<0.05) between the cell lines exists, thus no 
treatment effects exist within the cell lines to the various FAD treatments but the cell types 
respond differently to various FAD treatments.
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FIG. 8. FAD toxicity observed in DC4 and DB46 cell lines. A dose response is observed 
in this experiment. FAD applied in the same concentrations as cytochrome c overwhelms both 
cell lines at T3 (5x10'  ^M). DC4 has no cell survival and DB46 has 0.33% cell survival at T3. 
(Different letters indicate significantly different means, p<0.05). All three concentrations are 
significantly different from TO (Control) as well as fi-om one another in both cell lines. Treatment 
response with respect to cell type (p<0.05) shows that the cell types respond the same to 
treatment and that the significance of difference is in the treatments.
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FIG. 9. FAD toxicity observed in MCF-7 and MDA-MB-435 cell lines. A response to 
FAD treatment is observed in both cell lines with the lowest survival occurring at the highest 
FAD concentration. (Different letters indicate significantly different means, p<0.05). In both cell 
lines a significant difference exists between TO (control) and treatments Tl (1x10'® M), T2 (1x10 
* M) and T3 (1x10^ M). In MCF-7 no significant difference exists between Tl and T2, but a 
significance difference is between T3 and Tl. In MDA-MB-435, T2 is not significantly different 
fi-om Tl but T3 is significantly different from Tl. The cell lines are significantly different and 
significance of treatment to cell type response depends on the cell type.
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FIG. 10. FAD toxicity observed in cell lines RKO and HFLl. FAD has effects on both 
cell lines. RKO responds to incubation with FAD but holds its survival rate steady above 70%. 
Incubation of HFLl with FAD shows a response as well. The lowest cell survival is observed at 
the highest concentration of FAD. (Different letters indicate significantly different means, 
p<0.05). A significant difference (p<0.05) was found to exist only between TO and Tl, T2, T3. 
No significant differences (p>0.05) exist between the three treatments. The cell lines are 
significantly different (p<0.05); therefore, treatment to cell response is only significant between 
the cell lines not within the cell lines. (Error bars with respect to TO and Tl in HFLl are large 
because of loss to mold).
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FIG. 11. MgCl; effects observed in DC4 and DB46 cell lines. MgCb was set up as a 
control to ensure that it did not have an effect on cell survival or cell kill when applied in solution 
with ATP. No effects were observed with DC4 and some cell proliferation was seen in DB46.
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FIG. 12. ATP toxicity observed in DC4 and DB46 cell lines. DB46 and DC4 respond to ATP 
treatments. A step function is observed in both cell hnes as well as similar responses to 
treatments. (Different letters indicate significantly different means, p<0.05). Significance 
regarding ATP treatment effects (p<0.05) exists only between TO (control) and Tl (IXIO'^M), T2 
(IXIC^M), T3 (IXIO ’M). No si^ificant differences (p>0.05) are found between treatments.
The cell lines do not respond significantly different to treatment (p>0.05), therefore no significant 
differences are found within cell hnes or between cell lines regarding treatment with ATP.
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FIG. 13. NADH toxicity observed in DC4 and DB46 cell Unes. NADH treatments result 
in cell death in DC4 and DB46 cell lines. A dose response is not observed in either cell line. 
(Different letters indicate significantly different means, p<0.05). The cell lines do not respond 
significantly different (p>0.05) to NADH treatment. Two significant differences are observed. 
The first significant difference is between TO (control) and the three treatments Tl (1X10 ^ ) ,  T2 
(1X10'® M), T3 (IXIO'^M). The second significant difference is between DC4 Tl and DC4 T2. 
Treatment response to cell type shows two significant effects regarding NADH treatment within 
the DC4 cell line indicated by the letters a, b and c, but no significant effects within the cell line 
DB46 or overall between the cell lines.
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FIG. 14. NADH effects observed in RKO and HFLl cell lines. Percent survival increases 
in response to NADH treatments in the RKO cell line but shows percent survival decrease in the 
HFLl cell line. No significant differences (p>0.05) regarding cell death are found within cell line 
RKO with respect to NADH treatments. A significant difference is found in HFLl in T3 with 
respect to TO (p<0.05). Treatment response to cell type showed a significant difference in T3 to 
T l within the HFLl ceU Une. Between the cell lines treatments T l and T2 (RKO) are 
significantly different firom T3 (HFLl) and T2 (HFLl) is significantly different from T2 (RKO). 
(Large error bars are due to decreased sample size because of mold contamination).
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FIG. 15. Incubation of DC4 and DB46 cell lines with DMSO. DMSO treatments did not 
have an effect on either cell line.
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FIG. 16. Qio toxicity observed in DC4 and DB46 cell lines. Qio showed an effect only at 
the highest concentration in both cell lines. A dose response is not observed. (Different letters 
indicate significantly different means, p<0.05). A significant difference in treatment (p<0.05) 
exists between T3 (IxlO'^M) and TO (0), Tl (IxlO ’M), T2 (IxlO^M). A significant difference 
(p<0.05) exists between the cell lines at T3. Treatment response with regard to cell type indicates 
that no significant differences exist within or between the two cell lines except at T3.
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FIG. 17. Qio toxicity observed in RKO and HFLl ceil lines. Qio has no effect on HFLl. 
RKO is sensitive at the lowest concentration only. No significant treatment effects (p>0.05) are 
found in either cell line. No significant differences (p>0.05) exist between the two cell lines with 
regard to treatment response and no significant differences exist with regard to treatment and cell 
type within or between cell types.
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Fig. 18. HSP27 induction by heat shock (HS) observed in cell lines. A, breast cancer cell 
lines DC4 and DB46 express higher levels of HSP27 after heat shock. HSP27 expression (0.001- 
1.0 pg) is seen at O.lpg and l.Opg. HS DC4 shows the same HSP27 expression as control (con.) 
DB46. HS DB46 shows about a 4-fold in increase of HSP27 expression after (HS). B, MCF-7 
expression of HSP27 does not change after HS. RKO HSP27 expression is reduced after HS. 
MDA-MB-435 (MD-435) shows about a 3-fold increase of HSP27 expression following HS. 
HSP27 (0.1 and 0.05 pg) expression is seen at 0.1 pg.
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Fig. 19. Cytochrome c toxicity and percent survival relative to HSP27 expression. This 
graph shows quantification numbers relative to 0.1 pg of HSP27 as seen in Fig. 18 A and B 
(p. 65). The values correspond to the following cell lines: DC4 - 0.053, MDA-MB-435 - 0.23, 
RKO - 0.63, HS DC4 - 1.16, DB46 - 1.16 and MCF-7 -14.56. A trend line shows that the more 
HSP27 expression is present in a breast cancer cell line, the more protection is provided against 
cytochrome c toxicity. What mechanism of protection the RKO cell line (colon cancer) has 
against cytochrome c toxicity is not clear. The level of HSP27 is not enough to provide as much 
protection as is observed. The percent survivals are at T3 from Table IV, p. 49.
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Fig. 20. FAD toxicity and percent survival relative to levels of HSP27 expression. This 
graph shows quantification numbers relative to 0.1 pg of HSP27 as seen in Fig. 18 A and B 
(p. 65). The râlues correspond to the following cell lines: DC4 - 0.53, MDA-MB-435 - 0.23, 
RKO - 0.63, DB46 - 1.16 and MCF-7 - 14.56. A trend line shows that the more HSP27 
expression is present in a breast cancer cell line, the more protection is provided against FAD 
toxicity. What mechanism of protection against FAD toxicity is present in the RKO cell line is 
not clear. The level of HSP27 is not enough to provide as much protection as is observed. The 
percent survivals are at T3 from Table IV, p. 49.
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CHAPTER 4 
DISCUSSION
Previous research has given evidence that HSP27 binds to cytochrome c (5). This 
binding prevents the formation of the apoptosome and thus inhibits apoptosis. The goal 
of this thesis is to investigate treatment effects of exogenous addition of cytochrome c to 
cells in various concentrations. Can cytochrome c overcome the protection that HSP27 
provides against cell death and therefore reduce cell proliferation? Given that cytochrome 
c is an electron carrier involved in the mitochondrial electron transport chain, can other 
electron carriers and components of this mitochondrial electron transport chain, 
overcome this protection provided by HSP27 as well? How do different cell lines 
respond to these treatment agents? Does HSP27 protect breast cancer cell lines more 
than other cell lines against different treatment agents? To answer these questions the 
following experiments were conducted and the results of these experiments are discussed 
in the following paragraphs.
Cytochrome c
Cytochrome c toxicity w as investigated using the cell lines DC4, D B 46, MCF-7, 
MDA-MB-435, RKO and HFLI. The first experiment was set up with DC4, HS DC4 
(heat shocked DC4) and DB46 (Fig. 4, p. 51). DC4 was heat shocked, which results in 
the induction of many heat shock proteins that are involved in cell rescue, including
68
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HSP27. The elevated expression of HSP27 in HS DC4 was confirmed by Western 
blotting (Fig. 18 A, p. 65). Cytochrome c treatments were applied in increasing 
concentrations (TO = 0, T1 = 5x10"  ^M, T2 = 5x10"  ^M, T3 = 5x10'^ M) and a dose 
response was observed. The results show that HS DC4 responds similar to DB46 in cell 
survival rate, which is explained by the elevated expression of HSP27. Observed total 
ceU survival at T3 is 41% and 44%, respectively. DC4 cell survival is 18% at T3. This 
result shows that DC4 is not able to tolerate cytochrome c toxicity as well as HS DC4 or 
DB46. The reduced survival rate can be explained by the low basal levels of HSP27, 
which are not enough to protect the cells fi'om the toxic effects of cytochrome c (refer to 
quantification results in Chapter 3, p. 38). The low basal levels of HSP27 in DC4 control 
(con.) were also confirmed with Western blotting (Fig. 18 A, p. 65). A statistical analysis 
of the increasing concentrations of cytochrome c was performed. A significant effect is 
seen in cytochrome c treatments (p<0.0001) on mean cell survival across each of the cell 
lines DC4, HS DC4 and DB46. Elevated levels of HSP27, as confirmed by Western 
blotting (Fig. 18 A, p. 65), are able to protect against the cytotoxic effects of cytochrome 
c. This protection gradually declines with increasing concentrations of cytochrome c 
with the least amount of protection by HSP27 against cell death observed at the highest 
concentration applied in T3. Statistical analysis shows that there are no significant 
differences (p>0.05) between TO and Tl; however, significant differences (p<0.05) exist 
between T2 with respect to TO, Tl and T3. Significant differences also exist between T3 
with respect to TO, Tl and T2. Additionally, statistical analysis shows that the cell lines 
DC4 and DB46 do respond significantly different to cytochrome c treatments, thus 
confirming the protection that HSP27 provides in DB46. In summary, it can be said that
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increasing concentrations of cytochrome c induce more cell death in these two breast 
cancer cell lines with DB46 displaying more protection against cell death than DC4 
because of its elevated levels ofHSP27.
The next cell lines exposed to exogenous cytochrome c were MCF-7 and MDA-MB- 
435. These two cell lines also responded in a dose dependent manner (Fig. 5, p. 52). 
MCF-7 shows more resistance to cytochrome c treatment than MDA-MB-435. At the 
highest concentration, T3, MCF-7 has 65% cell survival, which is about 30% more than 
the MDA-MB-435 cell line at that concentration. Western blotting (Fig. 18 B, p. 65) 
showed that MCF-7 had much more HSP27 expression than MDA-MB-435 (refer to 
Chapter 3, p. 38, for quantification numbers), which resulted in more protection from the 
cytotoxic effects of cytochrome c. Statistical analysis (p<0.0001) also confirmed a 
significant effect of cytochrome c treatment regarding mean cell survivals in these two 
cell lines. The cell lines showed similar patterns to the DC4 and DB46 cell lines. Again 
no significant differences (p>0.05) are found between TO and Tl but T2 is significantly 
different from T3 (p<0.05). T2 and T3 are significantly different from TO and Tl as well. 
The cell types, MCF-7 and MDA-MB-435, are not significantly different and the 
treatment to cell type response shows that T3 had the most significant effect on both cell 
lines. HSP27 was able to give more protection against cell death in the cell line that 
expressed higher levels of this protein, namely MCF-7.
RKO was resistant to all cytochrome c concentrations (TO = 0, Tl = 5x10"*M, T2 = 
5xlO'^M and T3 = 5xlO‘^ M) with 100% survival at all concentrations. HFLI was 
sensitive to cytochrome c only at the highest concentration (T3) with 55% cell survival 
(Fig. 6, p. 53). Western blotting showed that RKO does not have a significant expression
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of HSP27. It is not clear if other HSPs such as HSPlOO or HSP70 play a role in cell 
survival in this cell line. What protects RKO cells against cytochrome c toxicity it not 
clear. It is not clear why only the highest dose of cytochrome c had an effect on the 
HFLI cell line. A statistical analysis (p=0.2566) shows that there are no significant 
differences across the mean cell survivals of both cell lines. Furthermore it was found 
that the cell lines are not significantly different (p>0.05) and the treatment to cell type 
response is only significant with respect to T3 in the cell line HFLI.
To summarize the above results it was found that cytochrome c is toxic. Breast 
cancer cells lines appear to be more sensitive to cytochrome c treatments than the other 
cell lines used in the experiments. This sensitivity may be related to HSP27 levels at 
least in breast cancer cell lines. HSP27 provides protection against cytochrome c toxicity 
and increasing cytochrome c concentrations can reduce the protection that HSP27 
provides.
FAD
FAD is involved in the mitchondrial electron transport chain and therefore was 
investigated for toxicity in DC4 & DB46 (Fig. 7, p. 54) as well as in the other four cell 
lines. The concentrations in the following treatments were TO = 0, Tl = IxlO'^M, T2 = 
IxlO'^M and T3 = IxIO'^M. At the highest concentration, T3, DB46 has a 57% cell 
survival, which is about 27% more than the DC4 cell line. The cytochrome c experiment 
showed that with increasing concentrations this electron carrier can overcome the 
protection that HSP27 provides against cell death. The same observation is made in the 
FAD experiments. DC4 has the least protection against the cytotoxic effects of FAD,
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which again can be explained by the low levels of HSP27 in this cell line. Statistical 
analysis (p<0.0001) shows high significance to mean cell survival regarding FAD 
treatments. The main effect (p<0.05) is seen in Tl, T2 and T3. All three treatments are 
significantly different from TO. T2 is significantly different from T3 but not from Tl.
The cell types show significant differences (p<0.05) but treatment to cell type response 
shows significant differences exist between the cell lines and not within the cell lines. 
Thus the elevated levels of HSP27 in DB46 account for the difference between the cell 
lines. Because of the elevated levels of HSP27 in DB46 and the low levels of HSP27 in 
DC4, the three treatments had about the same effects within each cell line but the cell 
lines each responded differently to treatment.
Given that FAD was this toxic at small concentrations, it was of interest to see what 
the effects of treatments at the same concentrations as cytochrome c (TO = 0, Tl = 5x10'’ 
M, T2 = 5x10^ M, T3 = 5x10'^ M) are (Fig. 8, p. 55). Results show that these treatments 
overwhelm the protection HSP27 can provide. A dose response is observed. DC4 shows 
about 14% and DB46 about 17% cell survival at Tl. The highest concentration shows no 
survival in the DC4 cell line and the DB46 cell line shows only 0.33% cell survival. 
Statistical analysis (p<0.0001) confirmed that there is a highly significant effect of FAD 
treatment on mean cell survivals averaging across both cell lines and treatment effects are 
significantly (p<0.05) different at increasing concentrations. This confirmed that all three 
treatments have significant effects on cell survivals.
MCF-7 and MDA-MB-435 also showed a response to this electron carrier (Fig. 9, 
p. 56). The concentrations of FAD were the same as in the first FAD experiment (TO = 0, 
Tl = IxlO'^M T2 = lxlO‘*M  T3 = 1x10'^M) and at the highest concentration, T3,
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MCF-7 had 64% cell survival, which was about 25% more cell survival than what was 
observed for MDA-MB-435. It can be speculated that HSP27 may have provided the 
protection against cell death in MCF-7. Statistical analysis (p<0.0001) shows 
significance across the mean cell survivals of these two cell lines. Further analysis of cell 
type (p<0.05) shows the cell types to be significantly different. Treatment analysis 
(p<0.05) in the MCF-7 cell line shows a significant difference between the three 
treatments (Tl, T2, T3) with respect to TO. In this cell line Tl and T2 are not 
significantly different fi’om one another but T3 is significantly different from Tl. In the 
MDA-MB-435 cell line T2 is not significantly different fi’om Tl but T3 is significantly 
from Tl. Thus treatment to cell type (p<0.05) shows that there are significant between the 
cell lines and significant treatment effect depends on the cell line.
FAD was observed to have an effect on RKO and HFLI cell lines (Fig. 10, p. 57).
Cell survival was 75% and 61%, respectively. FAD shows a significant effect 
(p<0.0001) in these two cell lines on mean cell survival. Treatment analysis (p<0.05) 
shows the treatments (Tl, T2, T3) not to be significantly different from one another. The 
cell types are significantly different (p<0.05) and treatment to cell type shows the 
treatments to be significantly different between the cell types not within the cell types and 
both cell lines show a similar pattern to FAD treatment.
To summarize the results, FAD is cytotoxic to all cell lines tested. HSP27 is able to 
provide some protection to breast cancer cell lines. FAD is more cytotoxic than 
cytochrome c. The cytotoxic effect of FAD is novel since we have not found any studies 
that have reported FAD cell toxicity.
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ATP
The unexpected results of FAD toxicity lead to the investigation of ATP toxicity. It 
has been shown that many different cell types experience cell death after prolonged 
exposure to 1 - 5 mM concentrations of extracellular ATP (48). The plasma membrane 
receptor P2X was found to be involved in this process (48). It is not known if stimulation 
of this receptor causes apoptosis or necrosis (48). Another discovery was that ATP can 
elicit a biphasic dose response (49). It was shown that at 800 pM, ATP is cytotoxic in a 
dose dependent manner, but between 800 - 2500 pM cell count increases markedly 
despite higher ATP concentrations (49). It is stated that the intracellular pathways are not 
well known and it appears that the perturbation in intracellular ion homeostasis plays a 
major role (48). Given that FAD and ATP both have an attached AMP moiety lead to the 
reasoning, that perhaps, FAD was utilizing an extracellular ATP receptor. In this 
experiment, DC4 and DB46 cell lines were treated with the same concentrations (TO = 0, 
Tl = IxlO'^M, T2 = 1x10’*M  T3 = 1x10'  ^M) as in the FAD experiments except ATP/ 
MgClz was used (Fig. 12, p. 59). As mentioned in Chapter 3 (Results) a control 
experiment was set up with MgCL to verify that it did not have any effect on these two 
cell lines because ATP has to have MgClz so the reaction can go forward. The 
experiment (Fig. 11, p. 58) showed that this was the case. The following experiment, 
which involved ATP in solution with MgCL did not show a dose response to ATP. The 
highest concentration (T3) showed a cell survival of 52% in DC4 and 63% in DB46.
DC4 showed 50% cell survival at Tl and 55% at T2 whereas DB46 showed cell survival 
of 52% at Tl and 61% survival at T2. Statistical analysis (p<0.0015) showed that the 
three treatments are significantly different from TO, the cell lines are not (p>0.05)
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significantly different from one another with regard to mean cell survival and treatment 
to cell type response shows that the results are non-significantly different.
In summary, we did not observe any biphasic results, which seems to be due to the 
much smaller concentrations that we used compared to what was listed in the literature 
above. We did find that ATP is cytotoxic to the breast cancer cell lines tested. ATP is as 
cytotoxic as FAD at low doses. HSP27 could provide some protection against ATP 
cytotoxicity. ATP and FAD both have an AMP moiety and display about the same 
cytotoxic effects on cell on breast cancer cell lines; however ATP is not an electron 
carrier, hence there must be a common mechanism through which ATP and FAD are able 
to induce cell death.
NADH
The next electron carrier involved in the mitochondrial electron transport chain with 
an attached AMP moiety is NADH. For the following experiments, concentrations were 
held the same as in the FAD and ATP experiments (TO = 0, Tl = 1x10'^M, T2 = 1x10'* 
M, T3 = 1x10'^ M). The exogenous addition of NADH to cell lines DC4 and DB46 
resulted in cell death (Fig. 13, p. 60). It is of interest that the lowest concentration, Tl, 
also yielded the lowest cell survival of 27%. The next concentration, T2, almost doubled 
the cell survival to 52% and the highest concentration, T3, resulted in survival reduction 
to 38%. DB46 had 40% cell survival at Tl, 42% cell survival at T2 and 40% cell 
survival at T3. Increasing NADH concentrations could not influence the survival rates 
in DB46. Statistical analysis shows an effect of NADH (p<0.0001) on the mean cell 
survival of the two cell lines. Treatment analysis (p<0.05) shows the three treatments not
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to be significantly different fi'om one another but to be significantly different fi'om TO.
The cell lines are not significantly different (p>0.05) and treatment to cell type analysis 
shows no significant differences within or between the cell lines with the exception of the 
relation of TO to the three treatments.
RKO and HFLI were treated with the same concentrations of NADH (Fig. 14, p. 61) 
as the two breast cancer cell lines. RKO responded to NADH concentrations with an 
increase of cell proliferation at Tl to 117% and T2 to 124% and down at T3 to 103%. A 
non-significant dose response was observed for HFLI where cell survival was observed 
fi'om TO -100%, T l-1 1 1%, T2 - 84% to T3 - 71% as concentrations increased.
Statistical analysis shows that there is no significant effect (p=0.2313) of NADH 
treatment on the two cell lines. Treatment analysis shows that the only significance is 
between Tl and T3, cell type analysis shows that cell types to be significantly different 
(p<0.05) but treatment to cell type response shows that even though the cell types are 
significantly different the treatments do not have any significant effects within the RKO 
cell line with respect to cell death induction, significance is only observed between cell 
lines RKO and HFLI with regard to T2 and T3, and as mentioned earlier within the 
HFLI cell line only between Tl and T3.
To summarize the results of the NADH experiments, NADH is cytotoxic in the breast 
cancer cell lines tested. NADH is more cytotoxic at Tl then FAD or ATP. HSP27 is not 
able to provide as much protection against cell death as it did in the FAD and ATP 
experiments. NADH like FAD and ATP has an attached AMP moiety. Observing that 
all three molecules, FAD, NADH and ATP, have about the same cytotoxic effects in 
breast cancer cell lines suggests for a common mechanism through which they reduce
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cell proliferation exists. We have not found any studies that have investigated NADH 
cell toxicity.
Qio
Observing that the three electron carriers that are involved in the respiratory chain 
effect cell survival, the fourth electron carrier that is part of this chain remained to be 
investigated as well.
Since Qiohad to be dissolved in DMSO (Chapter 2, p. 33), DMSO was set up as a 
control to show that it was not able to induce cell death (Fig. 15, p. 62). The results of 
the experiment were as expected. DMSO did not induce cell death. With this 
confirmation, Qio was added exogenously to cell lines DC4 and DB46 in the following 
increasing concentrations: TO = 0, Tl = IxlO'^M, T2 = IxlO'^M and T3 = IxlO'^M (Fig. 
16, p. 63). Only the highest concentration, T3, was observed to have an effect on DC4 
and DB46 with cell survival being 53% and 74% respectively. Statistical analysis 
(p<0.0017) shows significant treatment effects of Qio with regard to T3. Analysis of cell 
type showed that the cell lines are not significantly different (p>0.05) and treatment to 
cell type analysis shows that even though the cell lines are not significantly different, T3 
with Qio is significant between and within the cell lines.
The RKO and HFLI cell lines were also checked for Qio toxicity (Fig. 17, p. 64). The 
concentrations, Tl = IxlO'^M T2 = IxlO'^M and T3 = IxlO'^M, were not able to induce 
any significant cell death in RKO. At Tl - 88% cell, T2 - 92% and T3 - 98% cell 
survival was observed. These results indicate that RKO was resistant to incubation with 
Qio. HFLI showed resistance to all concentrations. Statistical analysis (p>0.9972)
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shows that no significant effects of Qio treatment were observed, the cell types are not 
significantly different (p>0.05) and effects of treatment to cell type are insignificant.
To summarize the above results, it appears that Qio is the least effective of the four 
electron carriers of the mitochondrial electron transport chain to induce cell death in 
breast cancer cells as well as other cell lines tested. One of the reasons may be that is 
was challenging to get Qio into solution with DMSO. As mentioned in Chapter 2 
(Materials and Methods, p. 26), a 15 ml centrifuge tube containing Qio in solution with 
DMSO was submerged halfway into beaker containing hot water. It may be that this 
heating denatured the electron carrier and therefore it was not as effective. This; 
however, does not explain the sudden drop in cell survival at T3 in DC4 and DB46. 
HSP27 provides protection against the cytotoxic effects of the electron carrier. Unlike 
the other electron carriers, Qio does not have an attached AMP moiety. More experiments 
need to be performed with this electron carrier.
Hypotheses
The first hypothesis in Chapter 1 was found to be true. Components of the electron 
transport chain, cytochrome c, FAD, ATP and NADH were able to reduce cell 
proliferation in human cancer and “normal” cell lines are. However, not all cell lines 
responded the same way. The second hypothesis was found to be true only in breast 
cancer cell lines that either overexpressed HSP27 or could have thermal induction 
thereby increasing expression of HSP27. In the HS DC4, DB46, MCF-7 and MDA-MB-
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435 cell lines HSP27 was able to give protection against the toxic effects of these 
electron carriers.
Table V (p. 81) gives a summary of the results.
Concluding Remarks
Of all tested electron carriers in these experiments it was observed that exogenous 
cytochorme c (Figure 4, p. 51) and FAD (Fig. 8, p. 55) were the only two electron 
carriers that were able to elicit a dose response at increasing concentrations in breast 
cancer cells. FAD (Fig. 7, p. 54), at lower concentrations showed a step response. What 
these experiments did not show was whether FAD induces apoptosis or necrosis and how 
or if it enters the cell.
To conclude the cytochrome c experiments, we observed a dose response in breast 
cancer cell lines following treatment with exogenous cytochrome c as the concentrations 
of exogenous cytochrome c were increased. Cytochrome c is shown to be cytotoxic in 
cell lines that constitutively express HSP27 or express elevated levels of HSP27 
following heat shock (Figures 4, 5, pp. 51, 52). What these experiments did not show 
was how or if exogenous cytochrome c enters the cell. If cytochrome c does not get into 
the cell, is there an extracellular receptor that this electron carrier binds to, donates 
electrons to and thereby initiates a pathway leading to cell death? Is this cell death then 
apoptosis or necrosis?
Future Work
It would be of interest to determine whether necrosis or apoptosis was induced in the
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performed experiments. There are several ways to identify apoptotic events in a cell. A 
flow cytometer can do a light scatter analysis. This application takes advantage of the 
refractive index. The refractive index of the internal cytoplasm of a dying cell becomes 
more similar to that of the extracellular medium. The addition of propidium iodide can 
identify those cells that have become permeable. A cell membrane analysis can be 
performed with a flow cytometer. Under normal circumstances phosphatidylserine (PS) 
residues are located in the inner membrane of the cytoplasmic membrane. These residues 
are translocated in the membrane and are externalized during apoptosis. Annexin -V  is a 
specific PS-binding protein that can be conjugated to fluorochromes. A fluorochrome 
can be combined with propidium iodide to identify dead cells. Nucleases are activated 
during apoptosis that degrade DNA. One way to detect these DNA fragments would be 
to use strand break labeling (TUNEL). TUNEL stands for Terminal deoxynucleotidyl 
transferase mediated dUTP Nick End Labelling. An enzyme is used to add dUTPs to the 
broken ends of DNA, which can then be detected by antibodies with fluorochrome labels. 
Staining with propidium iodide makes it possible to tell during which phase of the cell 
cycle the cells are exhibiting strand breaks.
It is not understood how exogenous cytochrome c treatments induce cell death. 
Therefore, determination of where exogenous cytochrome c binds outside of the cell or if 
exogenous cytochrome c binds to HSP27 could be answered by using fluorescent 
tagging.
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Table V
Summary o f electron transport chain components, their effects and HSP27 protection
observed
Cell Line e' Carrier Cell Death Induced HSP27 Protection
DC4 Cytochrome c Yes No
FAD Yes No
ATP Yes No
NADH Yes No
Qio Yes No
DB46 Cytochrome c Yes Yes
FAD Yes Yes
ATP Yes a
NADH Yes a
Qio Yes Yes
MCF-7 Cytochrome c Yes Yes
FAD Yes Yes
ATP N/A N/A
NADH N/A N/A
Qio N/A N/A
MDA-MB-435 Cytochrome c Yes b
FAD Yes b
ATP N/A N/A
NADH N/A N/A
Qio N/A N/A
N/A = not applicable 
a = no protection observed at dose applied
b = results are consistent with HSP27 protection but does not prove that other factors may 
not have contributed to cell survival
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